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Summary  
 
Defense against pathogenic microorganisms requires extensive communication between 
cells of the innate and adaptive immune system. T cell recognition of an antigen in the surface of 
an antigen-presenting cell (APC) leads to the formation of a specialized membrane-based 
structure at the interface of the APC and the T lymphocyte that favor transient cell-cell 
communication. This molecular assembly, termed immune synapse (IS) is a highly dynamic 
structure where polarized macromolecular components such as T cell receptors, adhesion 
molecules, cytoskeletal components and related organelles, orchestrate the early events of T cell 
activation. Following IS formation and T cell activation, T cells undergo a process of rapid clonal 
expansion and differentiation that give rise to the different types of effector and memory T cells. 
Immune signals and key metabolic cues present in the inflammatory milieu drive the expression 
of ‘lineage-specific’ transcription factors that ultimately guide the development of the different 
effector T cell subsets, which produce a specific repertoire of cytokines that determine the nature 
of the immune response and avoid autoimmune diseases. 
In this work, we have addressed the role of mitochondria in the regulation of adaptive 
immune responses. Our results uncover a fundamental role of mitochondria in almost every step 
of T cell function, starting with the control of IS organization and early TCR signaling to T cell 
differentiation, cytokine production and regulation of the outcome of immune responses. By 
regulating IS organization and the balance between OXPHOS and glycolysis, mitochondria 
provide a metabolic context appropriate for efficient regulation of inflammatory responses. In 
addition, we demonstrate a functional crosstalk of mitochondria and the biogenesis and function 
of endolysosomal compartment, linking for the first time mitochondrial deficiencies with 
lysosomal storage disorders. 
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Resumen 
 
La defensa contra los microorganismos patógenos requiere una amplia comunicación 
entre las células del sistema inmune innato y adaptativo. El reconocimiento por parte de las células 
T de un antígeno en la superficie de una célula presentadora de antígeno promueve la formación 
de una estructura altamente especializada que favorece la comunicación transitoria célula-célula. 
Este conjunto, denominado sinapsis inmune, es una estructura altamente dinámica donde se 
polarizan diversos componentes macromoleculares; como los receptores de células T (TCR), 
moléculas de adhesión, componentes del citoesqueleto y orgánulos contiguos, orquestando así los 
primeros acontecimientos de la activación de la célula T. Posteriormente a la formación de la 
sinapsis inmune y la activación de las células T, estas experimentan un proceso de rápida 
expansión clonal y diferenciación, dando lugar a los diferentes tipos de células T efectoras y de 
memoria. Las distintas señales inmunes y metabólicas presentes en el nicho inflamatorio 
promueven la expresión de factores de transcripción específicos de los diferentes linajes celulares 
Estos factores de transcripción guían el desarrollo de los diferentes subconjuntos de células T 
efectoras, productoras de un repertorio de citoquinas que determinan la naturaleza de la respuesta 
inmune y evitan la aparición de enfermedades autoinmunes. 
En este trabajo hemos abordado el papel de la mitocondria en la regulación de la respuesta 
inmune adaptativa. Nuestros resultados revelan un papel fundamental de las mitocondrias en casi 
todos los pasos de la función de las células T, comenzando con el control de la organización de 
la sinapsis inmune y la señalización temprana del TCR, hasta su diferenciación, la producción de 
citoquinas y el control final de la respuesta inmune. Mediante la regulación de la sinapsis inmune 
y del balance entre la fosforilación oxidativa y la glicólisis, las mitocondrias proporcionan un 
contexto metabólico adecuado para la regulación eficaz de la respuesta inflamatoria. Además, 
demostramos la existencia de una comunicación funcional entre las mitocondrias y la biogénesis 
y función del compartimento endolisosomal, relacionando por primera vez deficiencias 
mitocondriales con los trastornos de depósito lisosomal.  
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1. Introduction  
 
Organelles are a distinguishing feature of eukaryotic cells. Among them, mitochondria 
are exceptional organelles that maintain features of their ancestral origin besides the billion years 
of endosymbiotic co-evolution. Mitochondria contain their own genome and maintain an 
electrochemical gradient that empowers organelle functions and sustains cell homeostasis. More 
importantly, mitochondria turned out to be central hubs of the signaling cascades that sense 
situations of cellular stress, inflammation and cell death (Galluzzi et al., 2012). 
Mitochondria are multifunctional organelles that regulate many cell processes, including 
calcium signaling, apoptosis and cell metabolism. A key function of mitochondria is the control 
of ATP production through oxidative phosphorylation (OXPHOS), the tricarboxylic acid cycle 
(TCA), and fatty acid ß-oxidation (FAO); however, mitochondria also modulate amino acid 
metabolism and supply metabolic intermediates needed to sustain cell growth, proliferation and 
differentiation (Friedman and Nunnari, 2014; McBride et al., 2006). Defects in mitochondrial 
homeostasis are closely linked to the development of cancer, inflammation, neurodegenerative 
diseases and metabolic disorders (Taylor and Turnbull, 2005), and are also a hallmark of aging 
(Lopez-Otin et al., 2013). However, the molecular mechanisms by which mitochondria contribute 
to human diseases remain far from being resolved. 
1.1 Mitochondria: form and function 
Mitochondria are double-membrane organelles consisting of an outer membrane 
surrounding an inner membrane of greater surface area. The space between the two membranes 
is termed the intermembrane space. Because of its greater surface area, the inner mitochondrial 
membrane (IMM) folds back on itself, creating compartments termed cristae. These cristae 
membranes concentrate the oxidative phosphorylation respiratory chain complexes, whereas the 
smooth mitochondrial outer membrane (OMM) encapsulates the inner membrane and an 
intermembrane space (Figure I1a). Functioning together with the Krebs' cycle in the 
mitochondrial matrix, the complexes I, III and IV of the respiratory chain pump protons from the 
matrix to the intermembrane space through the coupled transfer of electrons to oxygen. The 
electrochemical gradient generated across the inner membrane is used to power ATP production 
by complex V (ATP synthase) in a process referred as oxidative phosphorylation (OXPHOS). 
Then, the ATP–ADP translocase exports the ATP into the intermembrane space, where it freely 
diffuses out of the outer membrane into the cytosol for fueling cellular processes (Figure I1b). 
The electrochemical potential is used for additional crucial mitochondrial functions, such as 
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buffering the signaling ion calcium (Ca2+) through uptake by a uniporter in the inner membrane. 
Interestingly, a reduction in the electrochemical potential has evolved as a read-out for 
mitochondrial functional status, which creates signals to activate pathways that repair and/or 
eliminate defective mitochondria (Galluzzi et al., 2012). 
 
 
Mitochondria are metabolic hubs within the cell that alter their function to meet cellular 
needs. This implies that mitochondria receive signals to change their function, but more 
importantly, accumulating evidence suggests that mitochondrial pathways provide signals back 
to the nucleus creating a crosstalk that integrate cell-fate decisions such as metabolic adaptation, 
proliferation, differentiation and cell death with metabolic capacity dependent on the cellular 
environment (Weinberg et al., 2015). Recent studies emphasize how mitochondrial activity, shape 
and localization appear as direct players in cell differentiation and developmental processes by 
 
(A) Electron microscopy image and representation of mitochondrial compartments. (B) The transfer of electrons 
through the electron transport chain (ETC) is used to pump protons (H+) from the mitochondrial matrix into the 
intermembrane space, creating an electrochemical proton gradient across the IMM called mitochondrial 
membrane potential (ΔΨ). The ΔΨ allows ATP synthase (complex V) to use the flow of H+ through the enzyme 
back into the matrix to generate ATP from ADP and inorganic phosphate. Complex I (NADH coenzyme Q 
reductase) accepts electrons from the Krebs cycle electron carrier NADH, and passes them to coenzyme Q 
(ubiquinone), which also receives electrons from complex II (succinate dehydrogenase). Ubiquinone passes 
electrons to complex III (cytochrome bc1 complex), which passes them to cytochrome c (cyt c). Cyt c passes 
electrons to Complex IV (cytochrome c oxidase), which uses the electrons and hydrogen ions to reduce 
molecular oxygen to water.  
Figure I1 
 
A 
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regulating signaling pathways such as the Notch or the Nf-kB pathways or the antiviral innate 
immune response (Kasahara and Scorrano, 2014).  
Several signal transduction mechanisms between mitochondria and the rest of the cell 
have been described. Anterograde signaling is the signal transduction from the cytosol to 
mitochondria. The best known example is the entrance of calcium into mitochondrial matrix upon 
elevations on cytosolic calcium concentrations (Rizzuto et al., 2012), which results in activation 
of multiple enzymes of the TCA cycle and the electron transport chain (ETC). The retrograde 
signaling is the signal transduction from mitochondria to the cytosol. Mitochondrial products such 
as mitochondrial ROS (mROS) regulate the activation of the hypoxia-inducible factor (HIF-1) 
(Chandel et al., 1998), whereas superoxide can induce thiol oxidation of proteins and modify their 
function (Murphy, 2009). Mitochondria can also impact signaling by altering the availability of 
TCA cycle intermediates such as acetyl-CoA, succinate, fumarate, and a-ketoglutarate, which 
modify and alter protein function or act as important signaling molecules (Boland et al., 2013; 
Buck et al., 2015) (Figure I2). In addition, mitochondrial bioenergetics status can also influence 
signaling pathways. The decrease in mitochondrial ATP production increases the concentration 
of AMP, causing a shift from an anabolic state to a catabolic state to sustain ATP-coupled 
reactions. The increase in AMP/ATP ratio triggers the activation of AMP-activated protein kinase 
(AMPK) that decreases mammalian target of rapamycin (mTOR) activity reducing anabolic 
reactions and increasing autophagy and FAO to increase metabolic supply by providing nutrients 
to mitochondria for generation of ATP (Pearce et al., 2013). Other example of retrograde signaling 
is the change in mitochondrial membrane potential that is sensed as readout of the functionality 
of mitochondria to activate processes such as mitophagy or apoptosis (Kasahara and Scorrano, 
2014). Finally, the OMM, serves as a signaling platform to allow coordinated interaction of 
proteins and signaling pathways (Weinberg et al., 2015). 
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Oxidative phosphorylation (OXPHOS); A two-step metabolic pathway that produces ATP from oxidation of nutrients and 
the transfer of electrons. First, pyruvate and fatty acids (FAs) are converted into acetyl-CoA, which enters the TCA cycle, 
producing free electrons carried by NADH and FADH2. Second, the electrons enter the electron transport chain, resulting in the 
movement of electrons out of mitochondrial matrix and the synthesis of ATP. 
Tricarboxilic Acid Cycle (TCA, Krebs cycle); acetyl-CoA derived from pyruvate and FAs is shuttled through eight enzymatic 
reactions in the mitochondria to generate the reducing equivalents NADH and FADH2 that fuel ATP production during 
OXPHOS. In addition, the cycle provides metabolites and NADH that function as aminoacid precursors, signaling molecules, 
or as substrates in other biochemical reactions.  
Fatty acid oxidation (FAO); metabolic process used to derive energy from the mobilization and oxidation of FAs, mainly in 
the mitochondrial matrix.  
Glycolysis; involves the enzymatic breakdown of glucose to pyruvate in the cytoplasm generating ATP and NADH. 
Glutaminolysis; a series of biochemical reactions in which the amino acid glutamine is degraded to glutamate and then to a-
ketoglutarate for further metabolism in the TCA cycle.  
Pentose Phosphate Pathways and Serine biosynthesis pathway; utilizes the six carbons of glucose to generate ribose-5-
phosphate (R5P) and glycine for the synthesis of the nucleotides and reducing equivalents in the form of NADPH for reductive 
biosynthesis reactions. 
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Cytosolic metabolic pathways converge on mitochondria where they constantly replenish the TCA 
cycle. TCA cycle intermediates can be further oxidized to generate ATP or they can be shuttled out of 
mitochondria into subsidiary pathways to generate cellular building blocks such as fatty acids (FAs). 
TCA cycle metabolites, in addition to other byproducts of mitochondrial metabolism, such as ROS, 
function as important signaling molecules that control cellular functions (Buck et al., 2015). 
Figure I2 
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1.1.1The mitochondrial genome 
Mitochondria have their own small circular genomes, encoding selected subunits of ATP 
synthesis and electron transport proteins that form the OXPHOS complexes, as well as transfer 
and ribosomal RNAs (tRNAs and rRNAs) (Figure I3A). The mitochondrial genome is ~16.6 
kilobases in length and contains 37 genes encoding 13 proteins, 2 ribosomal RNAs and 22 tRNAs. 
The 13 polypeptides are distributed among the OXPHOS protein complexes I, III, IV and V 
whereas complex II is entirely encoded by the nuclear genome (Figure I3B). The 2 rRNAs and 
22 tRNAs encoded by the mitochondrial DNA (mtDNA) are essential for the mitochondrial 
translational machinery that is used to generate the 13 polypeptides. The remaining proteins 
(>1,000) in the mitochondrial proteome are encoded by the nuclear genome, synthesized in the 
cytosol and imported into the mitochondria. Since the subunits of the respiratory complexes are 
encoded by nuclear and mtDNA, communication among both genomes is critical to maintaining 
        
 
The mitochondrial genome resides within the inner membranes of the mitochondrion. It consists of 
a heavy (H) and a light (L) strand, coding regions that contain no introns and the displacement loop (D-loop), where 
transcription and replication factors interact. (B) The mtDNA encodes 13 polypeptides contributing to complexes I, III, 
IV and V of the ETC, whereas the remaining subunits are encoded by the genomic DNA. Of note, mutations in the 
mitochondrial genome are usually associated to Complex I deficiency since seven of its subunits are encoded by mtDNA. 
(C) mtDNA replication is mediated by several nuclear-encoded transcription and replication factors, which along with 
mtDNA are packaged forming the mitochondrial nucleoid. The number of mitochondrial nucleoids per mitochondrion 
ranges from 1 to 10 (Satoh and Kuroiwa, 1991) and contain proteins involved in mtDNA replication, translation and 
protein assembly (TFAM, TFBM, POLGA, POLGB, MTSSB, Twinkle and ATAD) (Legros et al., 2004).  
 
Figure I3 
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the function of the electron transport chain and is associated with organism life-span (Feng et al., 
2001; Gomes et al., 2013; Houtkooper et al., 2013).  
A typical human cell contains hundreds of copies of mtDNA, which are grouped in 
protein-rich complexes called nucleoids, with between one and eight genome copies per nucleoid 
(Legros et al., 2004) (Figure I3C). The nuclear-encoded mitochondrial transcription factor A 
(Tfam) is the most abundant mtDNA-associated protein in mammalian cells (Friedman and 
Nunnari, 2014). This factor plays a crucial role in mtDNA transcription, and its expression 
controls mtDNA copy number in cells, thus being an essential player in the maintenance, 
transcription, and replication of mtDNA (Ekstrand et al., 2004; Larsson et al., 1998; Ngo et al., 
2011; Rubio-Cosials et al., 2011). Global deletion of Tfam causes embryonic lethality (Larsson 
et al., 1998), but tissue-specific ablation of this factor disrupts respiratory chain function in 
selected cell populations and generates a variety of alterations that recapitulate important 
phenotypes of human mitochondrial diseases (Ekstrand et al., 2007; Hansson et al., 2004; 
Vernochet et al., 2012; Viader et al., 2013; Wang et al., 1999). 
 
1.2 Mitochondrial dynamics  
The activity of mitochondria is regulated by their number, shape and positioning, features 
that are modified in response to changing circumstances such as oxygen availability or stress 
(Acin-Perez et al., 2014; Detmer and Chan, 2007; Lapuente-Brun et al., 2013). Our view on how 
mitochondria are organized within cells and function has changed since the description of the 
machinery involved in their fusion and fission (Chen and Chan, 2005). Mitochondria are no longer 
considered discrete organelles. Instead, mitochondria form a highly dynamic tubular network that 
is continuously remodeled by opposing processes of fusion and fission (Chan, 2006). During 
mitochondrial fusion, two mitochondria merge their outer and inner membranes, resulting in a 
single, larger mitochondrion. Mitochondrial fission is the opposite process, whereby a 
mitochondrion divides into two organelles (Figure I4).  
Mitochondrial fission and fusion is controlled by a family of dynamin related GTPases 
highly conserved between yeast, flies, and mammals (Hoppins, 2014). Their combined actions 
divide and fuse the two lipid bilayers that surround mitochondria. Constriction and fission is 
driven by the dynamin-related protein 1 (Drp1) (Smirnova et al., 2001).  In the cytosol, Drp1 is 
activated and recruited to the OMM and form spirals that constrict inner and outer membranes to 
induce division of the organelle into two separate entities.  The activity of Drp1 is highly regulated 
by post‐translational modifications (Cereghetti et al., 2008; Guo et al., 2013; Harder et al., 2004). 
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To date, four Drp1 receptors located in the outer mitochondrial membrane have been described 
in mammals; mitochondrial fission 1 (FIS1), mitochondrial fission factor (MFF), mitochondrial 
dynamics protein of 49 KDa (MID49) and MID51, which promote Drp1 recruitment often at sites 
where mitochondria contact with the endoplasmic reticulum (ER) (Friedman et al., 2011). 
Mitochondrial fusion consists of two 
sequential steps; first, the outer membranes of two 
mitochondria fuse; second, the inner membranes fuse. 
Tethering and fusion between mitochondrial outer 
membranes is mediated by membrane-anchored 
dynamin family members named mitofusin 1 (Mfn1) 
and Mfn2 in mammals (Santel and Fuller, 2001), 
whereas fusion between mitochondrial inner 
membranes is mediated by a single dynamin family 
member called optic atrophy 1 (Opa1) in mammals. 
Although Mfn1 and Mfn2 are highly homologous to 
one another, they have different roles in cell 
physiology. Mfn2 is the more versatile and 
participates in cell metabolism, tethering the ER to 
mitochondria and cell proliferation (de Brito and 
Scorrano, 2008). Moreover, mutations in the MFN2 
gene are associated with the peripheral neuropathy Charcot–Marie–Tooth disease type 2A 
(Zuchner et al., 2006). Interestingly, OPA1 has other non-fusogenic functions: regulates apoptosis 
by controlling the structure of cristae and the release of cytochrome c (Frezza et al., 2006), and 
regulates mitochondrial cristae shape, critical in respiratory chain supercomplex assembly and 
respiratory efficiency (Cogliati et al., 2013). 
Although the precise function of mitochondrial dynamics is still obscure, recent evidence 
suggests that fission and fusion are critical for maintaining a healthy mitochondrial population 
(Figure I5A, B). Complete deficiency in any of these proteins is embryonically lethal in mice, and 
mutations in some of these proteins are associated with neuromuscular disease in humans (Chen 
et al., 2003; Ishihara et al., 2009; Wakabayashi et al., 2009). But, how fusion and fission maintain 
the proper function in mitochondria? Cells lacking MFNs or OPA1 show heterogeneity among 
mitochondria in protein content, mtDNA nucleoid content and membrane potential, that results 
in defects in respiratory chain function and accumulation of mtDNA deletions (Chen and Chan, 
2005; Chen et al., 2007; Chen et al., 2010). Thus, cycles of fusion and fission facilitate the 
exchange of molecules such as metabolites, DNA and enzymes from healthy to dysfunctional 
     
 
Mitochondrial fission and fusion 
Figure I4 
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(A) Life cycle of mitochondria. Growth and division 
of mitochondria ends with the degradation of impaired or 
excess organelles by mitophagy. Mitochondrial dynamics 
remodels constantly the mitochondrial network and generate 
multiple heterogeneous mitochondria and segregate 
“dysfunctional” mitochondria that can be eliminated by 
selective autophagy. 
(B) Proposed functions of mitochondrial 
dynamics. Fusion of mitochondria allows the 
complementation of mtDNA gene products in heteroplasmic 
cells to counteract the decline of respiratory functions in aging 
and the transmission of membrane potential within the 
mitochondrial network. Mitochondrial fission is involved in 
mitochondrial inheritance during cell division, the release of 
pro-apoptotic factors, the cellular positioning to specific sites 
by cytoskeleton-mediated transport and the turnover of 
damaged organelles by mitophagy (Westermann, 2010).  
 
mitochondria (Chen et al., 2005). Fusion between mitochondria can also rescue two mitochondria 
with mutations in different genes by cross-complementation to one another, and it can mitigate 
the effects of environmental damage through the exchange of proteins and lipids with other 
mitochondria (Mishra and Chan, 2014). Interestingly, although functional mitochondria 
continually mix their contents, quality control mechanisms prevent dysfunctional mitochondria 
from fusing with healthy mitochondria, for instance by promoting the proteolytic inactivation of 
OPA1 (Ishihara et al., 2006). Mitochondrial fission allows the selective targeting of damaged 
mitochondria for degradation via macroautophagy (Twig et al., 2008). Additionally, fission is 
also required for the proper distribution of mitochondria to daughter cells during mitosis (Taguchi 
et al., 2007), essential for growing and dividing cells to populate them with adequate numbers of 
mitochondria, and the asymmetric partitioning of mitochondria during stem cell division 
(Campello et al., 2006; Kanfer et al., 2015; Katajisto et al., 2015; Li et al., 2004; Varadi et al., 
2004). 
 
A 
 
B 
 
   
Figure I5 
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1.3 Positioning mitochondria to specific subcellular locations  
The cytosolic localization of mitochondria is not random: these organelles accumulate 
where high amounts of ATP are required, or where Ca2+ signaling needs to be regulated. 
Mitochondrial movement is highly coordinated with changes in organelle shape in order to 
produce mitochondria whose size is compatible with their movement. Mitochondrial distribution 
within the cell depends on mitochondrial trafficking along the cytoskeleton. For example, the 
expression of pro‐fusion shaping proteins decreases mitochondrial movement along axons and 
dendrites and consequently reduces the number of dendritic spines and synapses (Li et al., 2004), 
the formation or maintenance of which require local levels of high mitochondrial ATP production. 
Similarly, mitochondria cluster at many sites of high ATP demand in different cell types. In 
Drosophila neuromuscular junctions, synaptic mitochondria are required to fuel the myosin 
ATPase that mobilizes a reserve pool of vesicles (Verstreken et al., 2005). Mitochondria 
specifically redistribute to and accumulate at the uropod during directed leukocyte migration to 
provide ATP, thus regulating the cell motor of migrating lymphocytes (Campello et al., 2006). 
The accumulation of mitochondria at the uropod requires their fission since promoting 
mitochondrial fusion blocks mitochondria and cell polarization in response to chemokines and 
prevents the migration of T lymphocytes. The inhibition of mitochondrial transport reflects an 
inability of the cytoskeleton to transport organelles that are too large or, alternatively, altered 
interaction between mitochondria shaping proteins and the components of the mitochondria 
transport machinery, such as the kinesin and dynein motors or the adaptor Miro–Milton complex 
(Liu et al., 2009). In this sense, disruption of the dynein-dynactin complex results in mitochondrial 
elongation caused by Drp1 blockage (Varadi et al., 2004), whereas MFN2 binding to Miro-Milton 
complex coordinate axonal transport of mitochondria (Misko et al., 2010). Similarly, Miro-1 links 
mitochondria to dynein complex and regulates mitochondrial positioning necessary for cell 
polarization and migration during lymphocyte adhesion to the endothelium (Morlino et al., 2014), 
which supports a model whereby the machinery that transports mitochondria is coordinated with 
mitochondrial shaping proteins. 
1.4 Communication between mitochondria and other intracellular organelles 
The crosstalk of mitochondria with other intracellular organelles is crucial during cell 
adaptation to stresses and for the preservation of organelle functionality (Klecker et al., 2014). 
Mitochondria interact with peroxisomes, lipid bodies or the plasma membrane, and these contacts 
are involved in lipid metabolism and regulation of calcium signaling (Naon and Scorrano, 2014). 
Mitochondria and the ER, form critical hubs implicated in the regulation of mitochondrial fission, 
calcium homeostasis, ATP production, apoptosis and lipid metabolism (de Brito and Scorrano, 
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2008; Osman et al., 2011; Rowland and Voeltz, 2012), and deregulation of these contacts can lead 
to disease (Area-Gomez et al., 2012; Arruda et al., 2014; Tubbs et al., 2014). Mitochondrial 
contacts with the lysosome-related vacuole in yeast (Elbaz-Alon et al., 2014; Honscher et al., 
2014) and with melanosomes in melanocytes (Daniele et al., 2014), have been shown to modulate 
lipid homeostasis and organelle function. Defining the intricate communication of mitochondria 
with other intracellular organelles is thus critical for understanding essential physiological 
processes and how their dysfunction might contribute to the development of human disease. 
The endolysosomal system is a dynamic compartment in which endosomes, lysosomes 
and multivesicular bodies (MVBs) mediate signaling, degradation and exosome secretion. Early 
endosomes regulate receptor signaling and direct endocytosed receptors back to the plasma 
membrane for repeated receptor signaling, or sort them for lysosomal degradation and signal 
termination. The maturation of early endosomes and the production of MVBs is a multistep 
process that includes changes in lipid composition and acidification of the endosomal 
compartment. Part of the MVB specific components traffic from the trans Golgi network (TGN), 
and may finally form part of the lysosomes. Therefore, MVB can be seen as an intermediate 
compartment where different compounds can be sorted for recycling instead of being directed to 
degradative pathways.  
During maturation of endosomes, inward budding of the limiting membranes of MVBs 
forms small intraluminal vesicles (ILVs). These vesicles can be secreted into the extracellular 
environment as exosomes and mediate cell-to-cell communication (Mittelbrunn and Sanchez-
Madrid, 2012) or, alternatively, are directed to the lysosome for degradation. Contrary to other 
types of extracellular vesicles, exosomes have endocytic origin (Raposo and Stoorvogel, 2013). 
Their secretion occurs in a constitutive manner although cellular stress or activation signals 
modulate their secretion (Villarroya-Beltri et al., 2014). Exosomes carry specific repertoires of 
proteins and nucleic acids that can transferred to neighboring cells and regulate at a distance the 
properties of receptor cells (Mittelbrunn and Sanchez-Madrid, 2012). Consequently, exosomes 
play a role in intercellular communication in several physiological processes, and contribute to 
organism development, immune responses, neuronal communication, and tissue repair (Yanez-
Mo et al., 2015). However, exosomes may participate in some pathological disorders, favoring 
tumor progression, virus dissemination and the spreading of toxic forms of aggregated proteins 
in neurodegenerative diseases (Bellingham et al., 2012).  
 Loading of proteins into exosomes is controlled through a variety of pathways (Figure 
I6). The endosomal sorting complexes required for transport (ESCRT) machinery is essential for 
the sorting of ubiquitinated membrane proteins and for the formation of ILVs in the MVB 
compartment. ILVs budding and protein sorting depend also on tetraspanin and lipid-dependent 
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interactions. The most abundant RNA species in exosomes are small rRNAs, fragmented tRNAs, 
and structural RNAs and are also highly enriched in specific set of microRNAs and mRNAs 
(Nolte-'t Hoen et al., 2012). An active sorting mechanism participates in RNA targeting into 
exosomes, which allows some RNA species to be particularly enriched in exosomes, whereas 
other RNAs are barely detected (Villarroya-Beltri et al., 2013). Although a great deal of effort has 
been placed on understanding the mechanisms of exosome cargo loading, less is known about the 
signals and the metabolic clues that coordinate the fate of MVBs between exosome secretion or 
their integration with the degradative and recycling pathways of the cell (Figure I7). 
 
              
 
     
 
Biogenesis and composition of Extracellular Vesicles (EVs). Blebbing of the cellular 
plasma membrane generates ectosomes whereas breakdown of dying cells forms apoptotic bodies. 
Exosomes derive from endosomal compartments through fusion of MVBs with the plasma membrane. 
Neutral sphingomyelinase 2 (nSMase2), ESCRT complex and RABs participate in ILV formation, protein 
sorting and exosome secretion, respectively. EVs, contain functional mRNA, microRNA (miRNA) and 
DNA molecules that can be taken up by recipient cells through mechanisms including fusion with the 
plasma membrane, phagocytosis and endocytosis. Exosomes contain proteins involved in membrane 
transport and fusion (such as RAB proteins and annexins), cytoskeletal proteins, adhesion molecules and 
tetraspanins. Exosome membranes are enriched in raft lipids such as cholesterol, ceramide and 
sphingolipids (Mittelbrunn and Sanchez-Madrid, 2012).  
 
Figure I6
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Lysosomes are recognized as the main degradative compartment of the cell. First 
described by the Nobel laureate Christian de Duve in the 1950s, lysosomes are responsible for 
proteolytic degradation and recycling of functional and damaged proteins and organelles. 
Lysosomes ensure continuous renewal and recycling of cellular constituents avoiding 
accumulation of harmful components. In addition to the catabolic function of lysosomes, these 
organelles participate in a range of physiological processes such as plasma membrane repair, bone 
and tissue remodeling, cell signaling, energy metabolism, immune response and cell death  
(Cuervo, 2013; Settembre et al., 2013b). Lysosomes contain a single-lipid bilayer membrane in 
which are located proteins involved in the acidification of the lysosomal lumen, fusion of the 
lysosome with other cellular structures such as late endosomes, autophagosomes and the plasma 
membrane, and transport of degradation products into and out of lysosomes (Saftig and 
Klumperman, 2009). The most important biochemical feature of the lysosome is its acidic lumen 
(pH 4.5-5.0), which allows higher enzymatic activity of the resident acidic hydrolases, and 
facilitates partial unfolding of the substrate proteins allowing endoproteases to gain access to 
internal peptide bonds. The generation of the lysosomal pH gradient is maintained by the 
lysosomal membrane (Mindell, 2012). The proton-pumping v-type ATPase, uses the energy of 
ATP hydrolysis to pump protons from the cytosol to the lumen creating a H+ concentration in the 
lysosome that is about 100-fold higher than that of cytosol. Lysosome biogenesis and function 
are subject to transcriptional regulation by the transcription factor EB (TFEB), which allows 
adaptation of lysosomal function to different physiological conditions (Medina et al., 2015; 
Sardiello et al., 2009; Settembre and Ballabio, 2011). Alterations to lysosome function and 
endolysosomal trafficking pathways are mostly found in lysosomal storage disorders (LSDs). 
LSDs are caused either by deficiency of lysosomal proteins or by changes in non-lysosomal 
proteins that result in the accumulation of undegraded substrates in lysosomes and abnormal 
storage of lipids such as sphingomyelins, triacylglycerides, glycosphingolipids or sphingosines 
(Boustany, 2013; Futerman and van Meer, 2004). Remarkably, lysosomal dysfunction in Gaucher 
disease blocks mitochondrial turnover by mitophagy (Osellame et al., 2013), thus connecting the 
lysosome degradation capacity to the maintenance of a healthy mitochondrial repertoire.  
However, whether mitochondria regulate the biogenesis and function of the endolysosomal 
compartment is still unknown. 
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1. 5 Mitochondrial function during adaptive immune responses 
The role of mitochondria in T cell function has been historically neglected because of the 
glycolytic nature of T lymphocytes. Recent observations, however, have elucidated the 
requirement for mitochondrial oxygen consumption, ATP and mROS in fueling many if not all 
the steps of T cell function; ranging from early T cell activation, survival and proliferation, to the 
final events leading to T cell differentiation and effector function (Chang et al., 2013; Gill and 
Levine, 2013; Kaminski et al., 2012; Sena et al., 2013; Yi et al., 2006). 
 
Crosstalk of the endolysosomal compartment in the maintenance of cellular homeostasis. Recycling 
mechanisms relay on endosome/autophagy and lysosomal function. Recycling pathways include: 
macroautophagy where whole cytosolic regions are sequestered inside autophagosomes that fuse either 
with MVBs or lysosomes, chaperone-mediated autophagy (CMA) where LAMP-2A acts as a receptor for 
hsc70 on the lysosome to deliver unfolded proteins into the lysosomal lumen, and microautophagy that 
involves engulfment of small cytoplasmic components by inward invagination of the lysosomal or 
endosomal membrane. Exosome secretion is an alternative way to alleviate stress when recycling pathways 
are compromised, with an impact in neighboring cells (Baixauli et al., 2014) 
Figure I7 
 
32 
 
 
1.5.1 Immune synapse formation and early T cell activation  
T cell recognition of an antigen in the surface of an antigen-presenting cell (APC) leads 
to the formation of a specialized membrane-based structure at the interface of the APC and the T 
lymphocyte that favor transient cell-cell communication (Figure I8). This assembly, termed 
immune synapse (IS) because of its similarity to the neurological synapse, is a highly dynamic 
structure where polarized macromolecular components orchestrate the early events of T cell 
activation (Grakoui et al., 1999; Monks et al., 1998; Wulfing and Davis, 1998). T cell relocates 
adhesion and activating receptors, cytoskeletal components and secretory organelles to the contact 
site with the APC. T cell receptors (TCRs) gather at this site, and form the central supramolecular 
activation cluster (cSMAC), which also includes CD3 and co-stimulatory receptors. The cSMAC 
is surrounded by a ring of adhesion receptors that form the peripheral SMAC (pSMAC) (Dustin 
et al., 1998; Mittelbrunn et al., 2004). Polarization of the cytoskeleton toward the IS involves 
polymerization of actin, which, together with myosin, forms a contractile ring that is important 
for the correct concentration of the TCR complex at the cSMAC (Ilani et al., 2009). The tubulin 
cytoskeleton also reorganizes, and the microtubule-organizing center (MTOC) is re-orientated 
toward the IS through the activity of dynein/dynactin molecular motors (Martin-Cofreces et al., 
2008). Under these circumstances, the cytoskeleton guides the redistribution of the secretory and 
Golgi apparatus (GA) toward the IS, which favors the polarized secretion and endocytic recycling 
of receptors at the IS (Martin-Cofreces et al., 2014). The MVB polarize toward the IS (Alonso et 
al., 2011; Calabia-Linares et al., 2011; Mittelbrunn et al., 2011).  
The localization of the MVB at the IS organize a dense actin network through interaction 
with the clathrin adaptor and Hrs at the lamella-like structure beneath the plasma membrane 
(Calabia-Linares et al., 2011). Synaptic MVBs support the active secretion of microRNA-loaded 
exosomes towards contacting APCs (Alonso et al., 2011; Calabia-Linares et al., 2011; 
Mittelbrunn et al., 2011). This unidirectional transference of functional microRNA mediated 
through exosomes appears as a novel mechanism of cell-to-cell communication and immune 
modulation (Mittelbrunn and Sanchez-Madrid, 2012). The release of miRNA-enriched exosomes 
from MVB to the intercellular space would be facilitated by the skeleton and proteins involved in 
fusion of membranes, such as the SNARES (Mittelbrunn et al., 2015). Additionally, the lipid 
composition of the limiting membrane of the MVB may act as a sensor to enhance or decrease 
the secretion of exosomes. Lack of diacylglycerol kinases (DGK) increases exosome secretion by 
stimulated T cells (Alonso et al., 2011) and prevents T cell anergy upon CD3 stimulation without 
costimulation (Joshi and Koretzky, 2013). In addition, lysobiphosphatidic acid (LBPA), a lipid 
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present in MVBs, is found at the cSMAC plasma membrane (Varma et al., 2006), which support 
the exocytic process from the MVB at the IS. 
T cell mitochondria relocate toward the IS during T cell activation (Abarca-Rojano et al., 
2009; Kummerow et al., 2009; Quintana et al., 2007). Mitochondria are required for efficient T 
cell activation by regulating calcium signaling and by producing ROS and ATP. Mitochondria 
act as efficient Ca2+ buffers and their translocation towards the IS is essential to maintain Ca2+ 
influx upon TCR stimulation by preventing the premature Ca2+‐dependent inactivation of 
CRAC/ORAI1 channels at the plasma membrane and calcium flux across plasma membrane 
(Kummerow et al., 2009; Quintana et al., 2011). Mitochondrial ROS generated at mitochondrial 
complexes III and I triggers an oxidative signaling indispensable for full antigen-specific T cell 
activation. T cells deficient for ubiquinol-cytochrome c reductase (Uqcrfs1), a component of 
complex III of the ETC, display impaired TCR-dependent ROS production and defects in antigen-
                   
The early steps of T cell activation, polarization and IS formation: after initial engagement of 
the TCR with its cognate peptide–MHC complex, the T cell stops migrating, polarizes and the MTOC is reoriented 
from the uropod to beneath the IS together with its associated organelles and vesicles (A-C). TCR molecules are 
recruited into the synapse whereas other cell-surface molecules are excluded (D). The sequential states in the 
assembly of the IS provide a framework for establishing checkpoints for cellular activation. In addition, the IS can 
regulate the initiation, balance and termination of signaling by accumulation of proteins at the IS to increase the rate 
of TCR triggering and the downregulation and degradation of TCR. (A) Confocal images from a T cell immune 
synapse formation between T cell and an APC (Ritter et al., 2015), (B) Transmission electron microscopy image 
show the extensive polarization of T cells upon IS formation, (C) diagram representing the polarization of 
cytoskeleton and related organelles towards the IS, and (D) IS architecture (Piragyte and Jun, 2012). 
Figure I8 
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specific proliferation. These cells, which are not bioenergetically compromised, can undergo 
homeostatic proliferation but they lack ROS-dependent signaling mechanisms needed for antigen-
specific T cell activation and subsequent clonal expansion (Sena et al., 2013). By regulating ROS 
levels, the mitochondrial antioxidant enzyme manganese superoxide dismutase (MnSOD/SOD2), 
modulates NF-κB- and AP-1-mediated transcription (Kaminski et al., 2012).  The regulation of 
the mitochondrial oxidative signal required for full T cell activation is also regulated by the ADP-
dependent glucokinase (ADPGK). Its activation deviates glycolytic metabolism toward 
mitochondrial glycerol-3-phosphate dehydrogenase (GPD) shuttle, resulting in hyperreduction of 
ubiquinone and ROS release from mitochondria which is required for NF-κB-dependent gene 
expression (Kaminski et al., 2012).  
Mitochondria play another critical role in T cell activation by producing ATP. ATP 
released from stimulated cells fuel autocrine purinergic signaling processes required for a 
successful immune response (Ledderose et al., 2014). TCR stimulation initially triggers the uptake 
of Ca2+ by mitochondria, which stimulates Ca2+-dependent dehydrogenases of the TCA cycle, 
driving mitochondrial ATP production by OXPHOS. Increased oxidative synthesis of ATP upon 
T cell activation is followed by its release through pannexin 1 channels to the extracellular space 
to stimulate purinergic P2X receptors that function as ATP-gated Ca2+ channels that facilitate Ca2+ 
influx. Besides the increasing appreciation on the role of mitochondria in the early steps of T cell 
activation,  the molecular mechanisms driving mitochondrial positioning at IS and their role in IS 
organization and TCR signaling have not been elucidated. 
 
1.5.2 The metabolic switch of T cell activation 
Following the early events of IS formation upon antigen recognition, T cells undergo a 
developmental program characterized by rapid growth, proliferation, and acquisition of 
specialized effector functions. This process is tightly controlled by the coordinated activity of 
immune cell-specific cytokines and transcription factors. Activation of T cells is an energetically 
demanding process, and naive CD4+ T cells must reprogram their metabolism to meet the costly 
biosynthetic and bioenergetic demands of T cell activation and proliferation (Pearce et al., 2013; 
Pollizzi and Powell, 2014). Immune cells transform from a state of relative metabolic quiescence 
or catabolic state to a highly active metabolic or anabolic state during the activation phase.  
Resting naïve T cells maintain low rates of glycolysis and predominantly oxidize glucose-
derived pyruvate via OXPHOS or engage FAO to make ATP. In this catabolic state, 
macromolecules are completely degraded and shuttled to energy-generating pathways to produce 
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ATP to maintain cellular homeostasis and allow long term survival during quiescence. However, 
upon T cell activation, cellular metabolism is reorganized to an anabolic state that balances the 
need for ATP with the need for metabolic intermediates that are required for the novo synthesis 
of macromolecules (Figure I9). 
The cytokines and transcription factors that act in the regulation of immune cell 
differentiation and function are closely linked to the metabolic reprogramming of T cells. T cell 
receptor (TCR) signaling directs this metabolic reprogramming of naïve T cells. TCR activation 
promotes the coordinated up-regulation of glucose and amino acid transporters (Pollizzi and 
Powell, 2014), that fuel glutaminolysis and glycolysis during T cell blastogenesis. Activation of 
T cells rapidly switches metabolic programs from FAO and pyruvate oxidation via the TCA cycle 
to aerobic glycolysis, the pentose phosphate pathway (PPP), and glutaminolysis (Wang et al., 
2011). This metabolic reprogramming in T cells is associated with a global change in the 
transcriptome linked to the up-regulation of the transcription factors c-Myc (Wang et al., 2011), 
estrogen-related receptor α (ERRα) (Michalek et al., 2011b) and Hif-1α activation, and which 
seems very similar to that described in cancer cells (Gordan et al., 2007; Shi et al., 2011; Wang 
et al., 2011). This process, also known as the Warburg effect from earlier work in cancer biology, 
is a common trait of actively proliferating cells and is characterized by the conversion of glucose-
derived pyruvate to lactate despite the availability of oxygen for complete glucose oxidation. It is 
important to note that OXPHOS is still engaged in activated T cells (Chang et al., 2013), although 
the production of lactate from pyruvate by aerobic glycolysis is the dominant pathway of glucose 
               
           Figure I9 
Different metabolic hallmarks of resting T cells (Tn), activated T cells (Teff) and memory T cells (Tm) 
(Pearce et al., 2013).  
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metabolism in T cells. Oligomycin, a specific inhibitor of mitochondrial ATP synthase, can block 
the expression of early activation markers after TCR ligation and blunts subsequent T cell 
proliferation (Chang et al., 2013), suggesting that the naive-to-effector transition requires either 
de novo production of ATP by mitochondria or specific signals generated during OXPHOS 
function such as mROS (Kaminski et al., 2012; Sena et al., 2013; Weinberg et al., 2015).  
 
1.5.3 Metabolic reprogramming in T cell differentiation and effector function   
Despite their diverse functions, T cell populations largely arise from the same pool of 
precursor naive CD4+ T cells upon antigen stimulation in the context of immune signals and key 
metabolic cues present in the inflammatory milieu (Pollizzi and Powell, 2014). Specific cytokines 
or combination of cytokines induce the expression of ‘lineage-specific’ transcription factors that 
ultimately guide the development of the different Th effector cell subsets (Figure I10). These 
include the pro-inflammatory T helper 1 (Th1), Th17, Th2, and regulatory T cells (Treg) that 
restrain inflammatory responses. Upon pathogen clearance, most Teff cells die, leaving behind a 
small population of long-lived antigen-specific memory T cells (Tm) that can be reactivated into 
rapidly expanding Teff cells if a similar infection occurs to quickly restrain the infection. The 
balance among the distinct functional effector and regulatory T cell subsets is thus decisive to 
determine the nature of the immune response and avoid autoimmune diseases. 
Similar to what was observed in the resting and activated state, a different T cell metabolic 
signature has been observed in T effector populations. Th1, Th2, and Th17 T cells specifically 
rely on glycolysis rather than mitochondrial metabolism, while Tregs show a requirement for lipid 
metabolism, glycolysis, and OXPHOS (Gerriets et al., 2015; Michalek et al., 2011a). Nutrient 
sensing and canonical signaling pathways such as  mammalian target of rapamycin (mTOR), 
phosphoinositide 3-kinase (P13K), and AKT, link immune signals and metabolic cues for the 
activation, development, function and differentiation of T cells (Chi, 2012; van der Windt and 
Pearce, 2012; Waickman and Powell, 2012). The mTOR pathway integrates diverse 
environmental inputs, including immune signals and metabolic cues that direct T-cell fate 
decisions between effector and regulatory T cell lineage commitment (Chi, 2012; Zeng et al., 
2013). mTORC1 signaling promotes Th1 and Th17 differentiation whereas mTORC2 signaling 
promotes Th2 differentiation  (Chi, 2012). In addition, CD4+ T cells that lack mTOR fail to 
differentiate into effector cells under appropriate skewing conditions and become Foxp3+ 
regulatory cells (Delgoffe et al., 2011).  
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 Tregs have elevated levels of OXPHOS and decreased glycolytic flux compared to Th17 
cells (Michalek et al., 2011a). The increased mitochondrial metabolism of Tregs is due to 
increased AMPK-dependent FAO since etomoxir, which inhibits FAO, impairs Treg 
differentiation (MacIver et al., 2011; Michalek et al., 2011a). Th17 cells, in contrast, show 
increased glycolytic metabolism which appears to be important to maintaining their Th17 lineage 
state. The increase in glycolysis observed in Th17 cells is due to increased HIF-1 stabilization. 
HIF-1, an oxygen sensitive transcription factor, regulates glycolytic gene expression in Th17 
cells and the balance between regulatory T cell and Th17 differentiation (Dang et al., 2011; Shi 
et al., 2011) by targeting Foxp3 for proteosomal degradation under normoxic and hypoxic 
conditions (Dang et al., 2011). 
 
                      
 
 
Host defense against pathogenic microorganisms requires extensive communication between innate 
and adaptive arms of the immune system. Signals from innate immune cells, induced by pathogens and 
inflammatory stimuli, drive naive CD4+ T cells to differentiate into one of several effector fates, 
including Th1, Th2, and Th17 cells and Treg cells, which dampen immune responses. The main 
signaling pathways activated and the master transcriptional factors driving each lineage are indicated. 
The cytokine products of differentiated T cells subsequently tailor immune responses to effectively 
eliminate intracellular and extracellular pathogens. 
 
Figure I10 
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Th17 cells are important in responses mounted against extracellular bacterial infections 
of the intestine and the airways (Korn et al., 2009). Despite providing a benefit in these settings, 
Th17 can play a pathologic role in the induction of several autoimmune diseases, including 
collagen-induced arthritis, experimental autoimmune encephalomyelitis (EAE), inflammatory 
bowel diseases, and inflammation-induced carcinogenesis (Bedoya et al., 2013). Mice with T cells 
deficient in HIF-1 show reduced Th17 cells, increased Treg cells, and resistance to Th17-
dependent EAE. The HIF-1 target pyruvate dehydrogenase kinase 1 (PDHK1) is expressed in 
Th17 cells, but not in Treg cells, and diminishing PDHK1, the negative regulator of pyruvate 
dehydrogenase (PDH) suppresses Th17 formation and increases Treg formation (Gerriets et al., 
2015). PDH converts pyruvate to acetyl-CoA in mitochondrial matrix and increasing PDHK1 
reduces PDH activity thus limiting acetyl-CoA availability. Pharmacologic inhibition of PDHK 
by dichloroacetate (DCA) in mice diminishes Th17 and promotes Tregs resulting in inhibition of 
Th17 dependent colitis and EAE pathologies (Gerriets et al., 2015).  
Memory T cells have a different metabolism from their activated effector T cell 
counterparts, and they do not use aerobic glycolysis but rely on mitochondrial FAO for 
development and long-term survival (van der Windt et al., 2012). Memory T cells maintain greater 
mitochondrial mass which is required to support their oxidative metabolism and mitochondrial 
respiratory capacity required for increased cellular longevity, allowing CD8 T memory cells to 
respond more rapidly upon secondary exposure to the antigen. Although still not fully understood, 
all these metabolic studies suggest that mitochondrial metabolism dictates the different 
inflammatory and suppressive T helper lineages. 
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Objectives 
2. OBJECTIVES  
 
Based on the previous studies and background knowledge on mitochondrial function we 
postulate the following hypothesis; mitochondria regulate the activation, proliferation and 
differentiation of T lymphocytes through (1) their active relocation and activity at the IS 
mediated by mitochondrial shaping proteins and (2) by integrating cellular metabolism and the 
function of the endolysosomal compartment. 
In order to challenge our hypothesis, we have addressed 3 main objectives;  
 
1) Dissect the molecular mechanisms driving mitochondrial positioning at IS and determine 
the role of mitochondria in IS organization and early TCR signaling.  
 
2) Define the requirements of mitochondrial metabolism in T cell activation and 
differentiation in vitro and in vivo.  
 
3) Assess the crosstalk of mitochondria with the endolysosomal compartment and its impact 
on intracellular homeostasis and T cell function. 
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3. Materials and methods  
 
3.1. Reagents and antibodies 
Fibronectin (FN), poly-L-lysine (PLL), tetramethylrhodamine methyl ester (TMRM), 
5,5’,6,6‘-tetrachloro-1,1’,3,3‘-tetraethylbenzimidazolcarbocyanine iodide (JC-1), carbonyl 
cyanide 4-(trifluoromethoxy)phenylhydrazone (FCCP), RU360, influenza hemagglutinin (HA) 
peptide, and FITC-conjugated or unconjugated anti-α-tubulin and anti-γ-tubulin were from 
Sigma-Aldrich (St. Louis, MO). Staphylococcus enterotoxin E (SEE) was from Toxin Technology 
(Sarasota, FL). Antibodies for western blot and immunofluorescence were as follows: the 
antibody T3b (anti-human-CD3), anti-human CD81, anti-ERMs, and anti-human CD63 (Tea3/18) 
were produced in our laboratory; Erk1/2 and p74-dynein Abs were from Millipore (Billerica, 
MA); anti-phospho-Erk1/2, anti-phospho-PLC-γ1 (Y783), anti-PLC-γ1, anti-p-AMPK (Thr172), 
anti-AMPK, and anti-HisH4 from Cell Signaling Technology (Denver, MA); monoclonal Drp1 
Ab and anti-p150 from BD Biosciences (Lexington, KY); polyclonal Drp1, phospho-specific Ser-
19 myosin regulatory light chain (MLC), anti-MLC2; anti-EEA1, anti-CD63, anti-CD81 (5A6) 
and anti-TOM20 Abs from Santa Cruz Biotechnology (Santa Cruz, CA); anti-MnSOD from 
Rockland (Gilberstsville, PA); anti-tubulin, anti-flotillin and anti-p62 from Sigma‐Aldrich (St 
Louis, MO); anti-TFAM, anti-CD63 (NKI/C-3), anti-HRS, anti-CO1, anti-NDUFA9, anti-Core-
1, anti-SDHA (FpSDH) and anti-TSG101 from Abcam; anti-TFEB from Bethyl Laboratories; 
anti-LAMP1 from Biolegend; anti-LBPA from Tebu-Bio; and anti-MnSOD from Enzo Life 
Sciences. Alexa 488-, 647-, and 568-labeled secondary antibodies, phalloidin 488, cell tracker 7-
amino-4-chloromethylcoumarin (CMAC), INDO-1, Fluo4-AM, Lysotracker Green, 
LysoSensor™ Yellow/Blue DND-160 and Mitotracker Orange were from Invitrogen (Carlsbad, 
CA). Goat anti-mouse peroxidase and goat anti-rabbit peroxidase were from Thermo Scientific. 
Hoechst 42 and 58 was from Molecular Probes. Leupeptin and sphingomyelin were from Sigma. 
3.2. Cells, plasmids and cell transfection.  
Human T lymphoblasts were obtained from human peripheral blood lymphocytes (PBLs) 
by treatment for 48 h with 1 µg/ml PHA, followed by 50 U/ml IL-2 in complete RPMI 1640 
medium until day 11. SEE-specific human T lymphoblasts were obtained as described (Ibiza et 
al., 2006). Vβ8+ Jurkat T cell clones (J77) and the lymphoblastoid Raji and Hom2 B cell lines 
were cultured in complete medium. HA-specific, Vβ3+ Jurkat T cells (CH7C17) were 
supplemented with 400 μg/ml hygromycin B and 4 μg/ml puromycin.  
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The human Jurkat T cell line and the oligodendroglia Oli-neu cell line were cultured in 
RPMI (Sigma) containing 10% fetal bovine serum (Invitrogen). FBalb/cJ and mt-ND6 (FG23-1) 
mutant cell line were grown in DMEM and supplemented with 10% fetal bovine serum 
(Invitrogen) (Acin-Perez et al., 2014). Human fibroblasts (control patient, a patient with a point 
mutation in the complex I subunit mt-ND5 gene (m.13513G>A), and a patient with a point 
mutation in the mt-tRNAAsn gene (m.5658T>C) were obtained from skin biopsies for research 
purposes after written informed consent in accordance with the Helsinki declaration. Fibroblasts 
were grown in DMEM and supplemented with 10% fetal bovine serum (Invitrogen). 
Plasmids encoding mtRFP, mtYFP, Drp1wtYFP, Drp1S647AYFP, Drp1S647DYFP 
were previously described (Cereghetti et al., 2008), and generously provided by Dr L Scorrano 
(University of Geneva, Switzerland). LC3-GFP-RFP tandem construct was a gift from Tamotsu 
Yoshimori (Addgene plasmid # 21074). pEGFP-parkin WT was a gift from Edward Fon 
(Addgene plasmid # 45875). T cell lines and human T lymphoblasts were transfected with DNA 
plasmids or with specific Drp1 double-stranded siRNAs against human Drp1 
(GGUGCCUGUAGGUGAUCAA) or negative control (Eurogentec) using the Gene Pulser II 
electroporation system (Bio-Rad Laboratories) or the Nucleofector system (Amaxa Biosystems, 
Gaithersburg, MD).Tfam-silenced Jurkat and Oli-Neu cells were generated by lentiviral infection. 
Briefly, HEK293T cells were co-transfected with Lipofectamine2000 (Invitrogen) with pCMV-
ΔR8.91-(Delta 8.9), pMD2.G-VSV-G and plasmids encoding shRNAs against Tfam (Open 
biosystems), and the corresponding control shRNAs pLKO.1 (Open Biosystems). Supernatants 
were collected after 48–72 h and filtered (0.45 μm). Oli-neu cells or Jurkat T cells were 
subsequently transduced with lentiviral vectors encoding shRNA targeting Tfam or with negative 
control pLKO.1 shControl and selected with RPMI medium containing puromycin (4 μg ml−1). 
Stable cell lines with downregulated Tfam were grown in the presence of 0.25 mM uridine and 1 
mM sodium pyruvate. 
 
3.3. Mice 
All animal experiments were performed in the specific pathogen-free facilities at the 
Centro Nacional de Investigaciones Cardiovasculares (CNIC) in accordance with European 
Union recommendations and institutional guidelines. Tfamfl/fl mice were kindly provided by N.G. 
Larsson (Larsson et al., 1998) and CD4+Cre+/wt mice were purchased from the Jackson Laboratory. 
Double heterozygotes (Tfam+/fl, CD4+Cre+/wt) were obtained and backcrossed to the Tfamfl/fl strain 
to generate tissue specific knockouts (CD4+Cre+/wt Tfamfl/fl).  
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3.4. T cell activation and differentiation 
3.4.1. T cell activation (human) 
For TCR stimulation, cells were left untreated or treated with T3b antibody (10 μg/ml) 
plus cross-linker (IgG, 5 μg/ml), with or without additional CD28 Ab (5 μg/ml) for co-stimulation. 
For antigenic stimulation, Raji cells were pulsed with 1 μg/ml SEE (20 min) and mixed with 
Jurkat cells or SEE-specific human T lymphoblasts (30 min); alternatively, Hom2 cells pulsed 
with 200 μg/ml HA peptide (3 h) were mixed with CH7C17 cells. Cells were lysed in 50 mM 
Tris-HCl, pH 7.5, containing 1% NP40, 0.2% Triton X-100, 150 mM NaCl, and phosphatase and 
protease inhibitors. 
3.4.2. T cell activation and differentiation (mice) 
Naive CD4+ T lymphocytes were obtained from cell suspensions prepared from spleen 
and peripheral lymph nodes (LN) of Tfamfl/fl (wild type) and CD4+Cre+/wt Tfamfl/fl (Tfam-/-) mice. 
Pooled spleen and LN cells were incubated for 30 min at 4ºC  with biotinylated antibodies to IgM, 
B220, CD19, CD8, Gr-1, CD44, CD25, MHC-II, F4/8, CD11c, CD11b and DX5 (BD 
Pharmingen) followed by extensive washing with PBS containing 1% BSA and 5mM EDTA. The 
cell suspension was incubated for 20 min at 4ºC with streptavidin microbeads (MACS; Miltenyi 
Biotec) and washed with PBS 1% BSA+5mM EDTA. Naive CD4+ T cells were obtained by 
negative selection using the auto-MACS Pro Separator (Miltenyi Biotec). For in vitro activation, 
naive CD4+ T cells were incubated in RPMI 1640 supplemented with 1% sodium pyruvate, 
penicillin, streptomycin, 50 mM 2-mercaptoethanol and uridine (0.25 mM) (all from Invitrogen) 
and 10% fetal calf serum (Sigma) in the presence of 5 μg ml−1 plastic-bound purified anti-CD3, 2 
μg ml−1 soluble anti-CD28 (eBioscience) and 100 U ml−1 human IL-2 (Glaxo). For Th0 conditions, 
anti-IFN-γ (4 μg ml−1) and IL-4 (4 μg ml−1) were added. For Th1 conditions, culture was 
supplemented with IL-12 (10 ng ml−1) and anti-IL-4 (4 μg ml−1). For Th2 conditions, IL-4 (10 
ng ml−1) and anti-IFN-γ (10 μg ml−1) were added. For Th17 conditions, anti-IL-2 (10 μg ml−1), 
anti-IL-4 (10 μg ml−1), anti-IFN-γ (10 μg ml−1), TGF-β (5 ng ml−1), IL-23 (20 ng ml−1) and 
IL-6 (20 ng ml−1) were included in cultures. For Treg cell differentiation, TGF-β (10 ng ml−1) 
was added. Cells were collected on day 6, or as indicated. To obtain differentiated T lymphoblasts, 
naive CD4+ cells were cultured for 36-48h with 2 μg ml−1 concanavalin A (Sigma), and 
subsequently 50 U ml−1 human recombinant IL-2 (Glaxo) was added to the medium every 2 days 
during a 4-6 day incubation. For lymphoblast restimulation, cells were activated overnight either 
with 50 ng ml−1 phorbol myristate acetate (PMA) and 750 ng ml−1 ionomycin.  
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For proliferation assays, cells were fluorescently labeled with 1 μM Cell Trace Violet 
(Invitrogen) for 10 min at room temperature and activated with anti-CD3 and anti-CD28. For 
intracellular cytokine staining, cells were stimulated at 37°C for 4 h in the presence of GolgiStop 
(BD PharMingen), PMA (Sigma), and ionomycin (Sigma). After 4 h, cells were collected with 5 
mM EDTA in PBS and fixed with 1% formaldehyde. Cells were then permeabilized with saponin 
(Sigma) solution (0.5% saponin in PBS) and stained with anti-IL-17, anti-FoxP3 or anti-IFN-γ 
(BD Biosciences). To gate on CD4+ T cells only, T cells were stained with anti-CD4 antibody 
(BD Biosciences). Data were acquired on a FACSCanto flow cytometer (BD Bioscience) and 
analyzed using the FLOWJO software (Tree Star).  
3.4.3 Flow cytometry analysis of lymphocyte populations  
Viable cells were identified by Hoechst 42 exclusion. Singlet cells were discerned with a 
stringent multiparametric gating strategy based on FSC and SSC (pulse width and height). For 
surface labeling, cells were stained with antibodies diluted in PBS-0.5% BSA on ice. For 
intracellular and surface staining, cells fixed with 1% formaldehyde were stained with the 
indicated primary and secondary antibodies diluted in PBS-0.5% BSA and 0.5% Saponin. Cell 
suspensions from spleen and lymph nodes were blocked with Fc-block (CD16/CD32, BD), 
washed in PBS and 1% BSA and incubated with the following primary antibodies diluted in PBS 
and 1% BSA: CD11b, CD11c, B220, CD3, CD4, CD8 and CD45.1 (BD Biosciences). 
Fluorochrome-conjugated antibodies were purchased from BD Biosciences or eBioscience. Cell 
sample data were acquired on a FACSCanto flow cytometer and analysed using FACSDiva 
software (BD Biosciences) and FlowJo software. 
3.4.4 Analysis of the extracellular levels of inflammatory cytokines bv ELISA 
Cell culture supernatants from equal amounts of activated CD4+ T cells and restimulated 
with PMA and ionomycin were assayed for mouse IL-17, IL-10, IL-6, IFN- and IL-4 (from 
eBioscience) by enzyme-linked immunosorbent assay (ELISA) based on colorimetric 
quantification. The absorbance at A405 nm was measured in a microplate reader (Bio-Rad Model 
550) and results were expressed as means of duplicate wells. 
3.4.5 Induction of a contact hypersensitivity (CHS) response  
CHS was induced by painting shaved mouse abdomen skin with 200 l 3% oxazolone (4-
Ethoxymethylene-2-phenyl-2-oxazolin-5-one, Sigma) diluted in ethanol. After 4 days mice were 
challenged with 20 l 1% oxazolone on each side of the right ear. The left ear was painted with 
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vehicle as a control. Ear thickness was measured every day for nine days. For analysis of the in 
vivo Th1 response, ear lymph nodes were removed from mice 5 days after challenge, single-cell 
suspensions were prepared, and intracellular staining of activated CD4+ T cells for IFN- was 
performed as described above. 
3.4.6 DSS-induced colitis model  
Colitis was induced in wild-type and Tfam-/- mice by daily administration of 3% dextran 
sodium sulfate (DSS, Mw 30.000–40.000) for 7 days in drinking water. The clinical parameters 
used to score the disease were weight loss, loose stools/diarrhea and presence of occult/gross 
bleeding. The animals were weighed before starting the treatment (initial weight) and every day 
until the end of the treatment. Animals were also checked daily for stool consistency and for the 
presence of blood in the stools. At the end of treatment, colons were processed for histological 
analysis to check for the presence of infiltrates in the lamina propia, and mesenteric lymph nodes 
were processed to study cytokine production of immune cells by flow cytometry. 
 
3.5. Mitochondrial function and metabolic assays 
3.5.1 Assessment of mitochondrial membrane potential (Δψm)  
 
The mitochondria-directed, fluorescent sensitive probe JC-1 was used to determine 
variations in mitochondrial membrane potential (Δψm) (Solaini et al., 2007) The reversible 
formation of JC-1 aggregates upon membrane polarization was detected as a shift in emitted light 
from 520 nm (JC-1 monomeric form, FL1) to 590 nm (JC-1 aggregate, FL2). To assess Δψm in 
stimulated Jurkat T cells or T lymphoblasts, cells preloaded with JC-1 (2 μg/ml) were analyzed 
by flow cytometry (FACScalibur, Becton Dickinson) and FL1 and FL2 laser emissions were 
recorded (330 V and 320 V, respectively). The mitochondrial depolarizing agent fluoro-carbonyl 
cyanide phenylhydrazone (FCCP, 250 nM) was used as a positive control. 
Ψm of single mitochondria was assessed as described (Twig et al., 2008). Briefly, 
mitoYFP-transfected T cells were loaded with 50 nM TMRM, washed twice and allowed to settle 
on CD3 plus CD28 Ab coated coverslips. A single Z confocal plane was acquired, corresponding 
to the cell contact with the activating surface, with a TCS SP5 confocal microscope. For every 
time point, the TMRM and mitoYFP fluorescences were used to determine changes in Δψm using 
the accompanying confocal software (LCS, Leica).  
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3.5.2 ATP content 
ATP content was analyzed in control and Drp1-silenced cells. Cells stimulated with CD3 
plus CD28 Abs were treated with vehicle or oligomycin (4 μM). Cells were then stained with 
MgGr –AM ester (Invitrogen, 5 μM) for 30 min. Emission intensity of the probe increases as a 
function of free Mg+2, but decreases with ATP content. Global ATP content in T cell lysates from 
wild-type and Tfam-/- T cells were measured with the ATP luciferase determination kit (Molecular 
Probes). Mitochondrial derived-ATP synthesis in T cell lysates was measured by a kinetic 
luminescence assay (Acin-Perez et al., 2014). 
3.5.3 Mitochondrial content and ROS  
Mitochondrial mass was measured from the fluorescence level after staining with 50 nM 
Mitotracker green (Life Technologies) for 30 min at 37°C. Mitochondria-associated ROS levels 
were measured by staining cells with 2.5μM MitoSOX (Life Technologies) for 30 min at 37 °C. 
Cytosolic ROS was measured with 2',7'-dichlorodihydrofluorescein diacetate (DCFDA; Life 
Technologies) for 30 min at 37°C. Cells were then washed with PBS and re-suspended in cold 
PBS containing 1% FBS for flow cytometry analysis. Dead cells were excluded by staining with 
Hoechst 42 (Sigma). 
3.5.4 Blue-native gel electrophoresis and mitochondrial complexes activities  
Cellular lysates from wild-type and Tfam-/- T lymphocytes were lysed in the presence of 
digitonin and proteins separated on 5–13% gradient blue-native gels (Lapuente-Brun et al., 2013). 
The activities of individual complexes were measured spectrophotometrically as previously 
described (Acin-Perez et al., 2014).  
3.5.5 Extracellular flux analysis and metabolic assays  
Oxygen consumption rates (OCR) and extracellular acidification rates (ECAR) were 
measured in a XF-96 Extracellular Flux Analyzers (Seahorse Bioscience) in cells suspended in 
XF medium (nonbuffered RPMI 1640 containing either 25 mM glucose or 1 mM palmitate, 2 mM 
L-glutamine, and 1 mM sodium pyruvate). Three measurements were obtained under basal 
conditions and upon addition of the mitochondrial inhibitors oligomycin (1 μM), to inhibit 
mitochondrial ATP synthase, FCCP (1.5 μM), to uncouple ATP synthesis from oxygen 
consumption by the electron-transport chain; and rotenone (100 nM) + antimycin A (1 μM), to 
inhibit the electron transport chain (all from Sigma). Basal oxygen consumption rate was 
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established by measurement the OCR in the absence of drugs. ATP was measured with the ATP 
determination kit (Invitrogen). 
3.5.6 Lipidomic analyses 
Ultra performance liquid chromatography coupled to mass spectrometry (UPLC-MS) was 
used for optimal profiling of glycerolipids, glycerophospholipids, sterol lipids and sphingolipids 
as described in (Barr et al., 2012). Briefly, cells were lysed and proteins precipitated by adding 4 
volumes of methanol at room temperature. After brief vortex mixing, chloroform was added to 
the samples at room temperature. Samples were incubated at -20 °C for 30 min and after brief 
vortex cell extracts were mixed with water (pH=9). Following brief vortex mixing, the samples 
were incubated for 1 h at -20 °C and afterwards centrifuged at 16,000 x g for 15 min. The organic 
phase was collected and dried by speed-vacuum centrifugation. Dried extracts were then 
reconstituted in acetronitrile/isopropanol (1:1), centrifuged (16,000 x g for 5 min), and transferred 
to vials for UPLC-MS analysis. Data pre-processing generated a list of chromatographic peak 
areas for the metabolites detected in each sample injection. Data were normalized using the 
procedure described in (van der Kloet et al., 2009). Univariate statistical analyses were performed 
to calculate group percentage changes, and unpaired Student’s t-test (or Welch’s t test where 
unequal variances were found) was used to compare Tfam-/- and wild-type T lymphocytes.  
3.5.7 Mitochondrial isolation and immunoblotting.  
For mitochondrial fractionation, cells were lysed in ice-cold isotonic sucrose buffer (10 
mM Tris pH 7.5, 0.25 M sucrose, 0.1 mM EDTA) containing protease and phosphatase inhibitors 
(Roche, Basel, Switzerland). Cells were then homogenized using a 23G needle. Lysates were spun 
at 1000 g (4ºC, 10 min) to remove debris and nuclei, and the supernatant was further centrifuged 
at 13000 g (4ºC, 30 min) to yield the mitochondrial fraction. Mitochondrial enriched fractions 
were washed and proteins resolved by SDS-PAGE and transferred to nitrocellulose membranes. 
After blocking, membranes were blotted with primary and peroxidase-labeled secondary 
antibodies and detected with western reagents (GE Healthcare, UK) and the LAS-3000 
chemiluminiscent system (Fujifilm).  
3.6. Immune synapse analysis 
3.6.1 Cell conjugate formation 
 Raji B cells or Hom2 B cells were loaded with the CMAC tracker and incubated with 
SEE or HA-peptide. T cells (1x105 cells) were mixed with APC (1:1), centrifuged at low speed 
to favor conjugate formation, gently resuspended, and plated onto poly-L-lysine(PLL)-coated 
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slides (50 μg ml−1). Cells were allowed to settle for 30 min at 37ºC, fixed with 4% 
paraformaldehyde in PBS, and permeabilized with 0.2% Triton X-100 in TBS for 5 min. Cells 
were processed for immunofluorescence, stained with the indicated primary antibodies (5 μg ml−1) 
followed by alexa488- or Rhodamine Red X-labeled secondary antibodies (5 μg ml−1), and 
mounted in Prolong antifade medium (Invitrogen). 
For time-lapse confocal microscopy analysis, Raji APCs (5x105; SEE-pulsed or unpulsed) 
were allowed to adhere to PLL coated coverslips in Attofluor open chambers (Invitrogen) at 37ºC 
in a 5% CO2 atmosphere. T cells were added (1:1 ratio) and a series of fluorescence and 
differential interference contrast frames were captured using a TCS SP5 confocal laser scanning 
unit attached to an inverted epifluorescence microscope (DMI6000) fitted with an HCX PL APO 
63x/1.40-0.6 oil objective. Images were acquired and processed with the accompanying confocal 
software (LCS; Leica). 
3.6.2 CD3, MTOC and mitochondria translocation 
To measure the maximum diameter of CD3 clusters, J77 T cells were preincubated at 
37ºC, 4h with 200nM FCCP (Fluka, Germany), 50µM mdivi-1, 4 µM oligomycin or DMSO 
(Sigma-Aldrich), and then incubated 30 min with SEE-pulsed or unpulsed CMAC-loaded Raji B 
cells. CD3 maximum diameter was quantified in 3 independent experiments using ImageJ 
software. 
CD3 organization at the IS was analyzed in APC-conjugated control and Drp1-silenced 
T cells. 3D Z-stacks of the cell-cell contact area were reconstructed, and maximum diameter and 
the number of CD3 clusters were quantified in 15-20 conjugates in at least 3 independent 
experiments. 
CD3, mitochondria, Drp1 and pMLC accumulation at the IS was quantified in J77 or 
CH7C17 T cells conjugated with antigen-pulsed or non-pulsed Raji or Hom2 cells loaded with 
CMAC. For quantification in individual ISs we used a home-made plugin for Image J software 
(http://rsbweb.nih.gov/ij/) called “Synapse Measures”. By comparing fluorescence signals from 
multiple regions of the T cell, APC, IS, and background fluorescence, the program yields accurate 
measurements of localized immunofluorescence. A detailed description of Synapse Measures, 
including the algorithms used, is described (Calabia-Linares et al., 2011).  
The proportion of conjugates showing redistribution of the T cell MTOC close to the APC 
contact area was determined as described (Ibiza et al., 2006).  
Mitochondrial accumulation at the IS was calculated as the ratio of the FI of T cell 
mitochondria located in the third of the cell near the APC contact area to the FI of the 
mitochondria in the rest of the cell.  
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3.6.3 Time-lapse fluorescence confocal microscopy and total internal reflection 
fluorescence microscopy (TIRFM) 
Activating planar lipid bilayers were formed in FCS2 flow chambers as previously 
described (Carrasco et al., 2004; Grakoui et al., 1999). Briefly, unlabeled GPI-linked ICAM-1 
liposomes and biotinylated lipids were mixed with 1,2-dioleoyl-PC (DOPC) lipids (Avanti Polar 
Lipids, Inc.) to obtain the molecular density required. The chambers were then blocked with 2% 
FCS in PBS and loaded with streptavidin labeled AlexaFluor-647 and monobiotinylated T3b Ab 
as surrogate antigen. T cells were injected into the warmed chamber (37ºC) at time zero, and were 
imaged with a Zeiss Axiovert LSM 510-META inverted microscope fitted with a 40x oil objective 
and analyzed with LSM 510 software (Zeiss, Germany) and ImageJ software. 
For TIRFM, J77 T cells transfected with mitoYFP were allowed to settle onto CD3 plus 
CD28 coated coverslips in Attofluor open chambers (Invitrogen), and mitochondria were 
visualized with a Leica AM TIRF MC M mounted on a Leica DMI 6000B microscope. Images 
were acquired and processed with the accompanying confocal software (LCS; Leica). 
3.7. Calcium measurements  
3.7.1 Calcium measurement in T cell-APCs conjugates.  
J77 cells were loaded with Fluo-4 AM (2μM) in HBSS containing 20 mM HEPES for 30 
min at 37ºC washed in 10% FCS RPMI medium and then in HBSS containing 20 mM HEPES 
and 1% FCS. Cells in 20 mM HEPES, 1% FCS HBSS were settled onto MatTek glass bottom 
dishes and CMAC-loaded Raji APCs were added at a 1:1 ratio. After 1 min of baseline recording, 
images were acquired every 15 s, using a TCS SP5 confocal laser scanning unit attached to an 
inverted epifluorescence microscope (DMI6000) fitted with an HCX PL APO 40x/1.40-0.6 oil 
objective. The 488 nm argon laser line was used to excite fluo4 fluorescence, which was measured 
using a band-pass filter from 505 to 550 nm and digitized to 12 bit resolution. Images were 
acquired and processed with the accompanying confocal software (LCS; Leica). The results are 
expressed as the fold increase in mean Fluo4 fluorescence intensity relative to the time before the 
T-APC stable contact. Ionomycin (0.5 μg/ml) was used as a positive control. 
3.7.2 Intracellular calcium levels by Flow Cytometry  
To track intracellular calcium levels, cells were incubated with Indo-1 (5 μg/ml) in pre-
warmed HBSS containing 10 mM HEPES and 1%FCS. After 30 min at 37ºC cells were washed 
and resuspended in HBSS containing 1% FCS, and protected from light at room temperature for 
15 min. Pre-warmed cells were activated with CD3 Ab (10 μg/ml). Ca2+i flux was measured as 
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the ratio of emission at 395-415 nm to 500-520 nm over time using an FACSCanto system (BD 
Biosciences), and analyzed with Flow-Jo Software. Ionomycin (0.5 μg/ml) was used as a positive 
control. 
 
3.7.3 Lysosomal calcium measurement by Flow Cytometry 
Lysosomal calcium was measured with the membrane-permeable calcium indicator Indo-
1 (Invitrogen). Cells were loaded as recommended by the manufacturer for 30-60 min at 20 °C, 
washed and calcium release assessed from the Indo-1 fluorescence intensity ratio at 340/380 nm, 
detected by flow cytometry on a FACSCanto flow cytometer equipped with a 355 laser. After 
basal recording, cells were treated with bafilomycin-A1 to promote lysosomal calcium release as 
described (Lloyd-Evans et al., 2008) for the indicated times. Results are expressed as the increase 
in the Indo-1 signal in bafilomycin A1- or ionomycin-treated cells relative to their basal levels. 
3.8. Electron microscopy 
Mitotracker Orange-loaded T cells, treated with vehicle (DMSO) or mdivi-1 inhibitor for 
4 h, were conjugated with CMAC-loaded, SEE-pulsed Raji cells (APC) for 30 min on poly-L-
Lys-coated coverslips (Bellco). Conjugates were fixed in 2.5% glutaraldehyde (Sigma-Aldrich) 
in PBS for 15 min, washed, and treated with 1% osmium tetroxide (Sigma-Aldrich) for 45 min. 
Samples were extensively washed with water and dehydrated through increasing concentrations 
of ethanol (25%, 50%, 75%, 95% and absolute). Samples were then embedded in DURCUPAN 
resin (Fluka) and stored overnight at room temperature. The resin column was polymerized by 
baking at 60ºC for 48 h, and ultrathin sections were cut and contrasted. Sections were examined 
with a JEOL JEM1010 electron microscope (100KV) equipped with a BioScan digital camera 
(Gatan). Images were monitored with DigitalMicrograph 3.1 (Gatan). T cell mitochondria 
perimeter, area and distance from the IS were analyzed with ImageJ software. 
Wild-type and Tfam-/- lymphoblasts and Jurkat T cells stably transfected with shControl 
and shTfam were fixed in 2.5% glutaraldehyde (Sigma-Aldrich) in PBS for 15 min, washed, and 
treated with 1% osmium tetroxide (Sigma-Aldrich) for 45 min. Samples were extensively washed 
with water and dehydrated through increasing concentrations of ethanol (25%, 50%, 75%, 95% 
and absolute). Samples were then embedded in DURCUPAN resin (Fluka) and stored overnight 
at room temperature. The resin column was polymerized by baking at 60°C for 48 h, and ultrathin 
sections were cut and contrasted. Sections were examined with a JEOL JEM1010 electron 
microscope (100 KV) equipped with a BioScan digital camera (Gatan). Images were monitored 
with DigitalMicrograph 3.1 (Gatan).  
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3.9. Exosome analysis 
3.9.1 Exosome purification and sucrose gradient purification 
Cells were cultured in RPMI medium supplemented with 10% exosome-depleted FBS 
(depleted of bovine exosomes by overnight centrifugation at 100,000 g). Supernatant fractions 
were collected from 16-20 h cell culture supernatants from equal number of cells, and exosomes 
were obtained by serial centrifugation as described (Thery et al., 2006). Briefly, cells were 
pelleted (320 g for 10 min) and the supernatant was centrifuged at 2,000 g for 15 min to discard 
debris and dead cells. Supernatant was collected, ultracentrifuged at 10,000 g for 30 min at 4 ºC 
(Beckman Coulter Optima L-100 XP, Beckman Coulter) and exosomes were pelleted by 
ultracentrifugation at 100,000 g for 70 min at 4 °C. The exosome pellet was washed in PBS and 
collected by ultracentrifugation at 100,000 g for 70 min. For sucrose density gradient, isolated 
exosomes were layered on the top of a discontinuous sucrose gradient and centrifuged with a 
SW40 rotor at 192,000 g and 4 °C for 18-20 h. Sucrose gradient fractions were prepared in a 
SW40 centrifuge tube (14 x 95 mm; Beckman Coulter), ranging from 2.5 M at the bottom to 0.4 
M at the top. Fractions of 1 mL were collected from the top of the gradient and vortexed. 
Exosomal proteins were extracted by precipitation with 1:1 ice-cold acetone for at least 2 h at -20 
ºC. Samples were then centrifuged and resuspended in an equal volume of loading buffer for 
analysis by western blot.   
3.9.2 Nanoparticle Tracking Analysis (NTA)  
Exosome number and size-distribution were analyzed by measuring the rate of Brownian 
motion using the NanoSight LM10 system, which is equipped with fast video capture and particle-
tracking software (NanoSight, Amesbury, U.K.). Samples were diluted before analysis to 2 x 108 
to 20 x 108 particles ml-1 and the relative concentration was calculated according to the dilution 
factor. Briefly, 0.5 ml of diluted supernatant was loaded into the sample chamber of an LM10 
unit (Nanosight, Malvern Instruments) and three 30 second videos were recorded of each sample. 
Data were analyzed with NTA 2.1 software (Nanosight). Samples were analyzed using manual 
shutter and gain adjustments, resulting in shutter speeds of 15 or 30 milliseconds and camera 
gains between 280 and 560. The detection threshold was kept above 2; blur was set to auto; and 
minimum expected particle size was set to 50 nm. 
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3.10. Cell and exosome western blot analysis 
Cells or exosome preparations were lysed in 50 mM Tris pH 7.5, containing 0.3 M NaCl, 
0.5% Triton X-100, 0.1% NP-40, and a cocktail of protease inhibitors (Roche). Cell lysates were 
cleared of nuclei by centrifugation at 15,000 g for 10 min. Protein extracts from cells or exosomes 
were separated by 4–12% SDS–PAGE and transferred to a nitrocellulose membrane (Biorad). 
Proteins were visualized with LAS-3000 after membrane incubation with specific antibodies (5 
μg ml−1) and secondary antibodies conjugated to peroxidase (5 μg ml−1). Band intensities were 
quantified using ImageJ software (NIH) and results are expressed relative to controls. 
3.11. Quantitative real-time-PCR and mtDNA content analysis  
Total RNA was extracted from cells using the RNeasy kit (QIAGEN) and cDNA was 
synthesized with the High Capacity cDNA Reverse Transcription Kit (Applied Biosystems). 
Triplicate reactions were run on a 7500 Fast Real Time PCR System (Applied Biosystems) using 
SYBR Green PCR reagents (Applied Biosystems). The expression of mRNA for genes of interest 
was normalized to the expression of β-actin and beta-2-microglobulin. Data were analyzed using 
Biogazelle QBasePlus software (Biogazelle). For analysis of mtDNA levels, total DNA was 
extracted with the DNeasy kit (QIAGEN). mtDNA was amplified using primers specific for the 
genes for mitochondrial cytochrome c oxidase subunit 1 (mtCO1) and mitochondrially encoded 
NADH dehydrogenase 1 (mtND1) and normalized to genomic DNA by amplification of the 
succinate dehydrogenase (SDH) nuclear gene.  
3.12 Confocal microscopy analysis of autophagy and mitophagy 
For autophagosome-lysosome fusion assays, shControl and shTfam Oli-Neu cells were 
transfected using Lipofectamine (Invitrogen) with LC3-GFP-RFP, and left untreated or treated 
with Rapamycin (Sigma) during 3 hr and LC3- GFP-RFP fluorescence was examined with a Leica 
SP5 confocal microscope (Leica) fitted with a 63X objective. Cells were acquired with the same 
laser parameters using the same image magnification. Images were processed and assembled 
using Leica software. The number of GFP, RFP and GFP- RFP-positive autophagosomes were 
analyzed using Image J imaging software (NIH). For mitophagy assays, shControl and shTfam 
Oli-Neu cells transfected with Parkin-GFP were left untreated or treated with carbonyl cyanide 
m-chlorophenyl hydrazone (CCCP, Sigma) during 3 hr and Parkin-GFP fluorescence was 
examined with a Leica SP5 confocal microscope (Leica) fitted with a 63X objective. Images were 
processed and assembled using Leica software and the area of Parkin-GFP fluorescence was 
analyzed with Image J imaging software (NIH). 
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3.13. Statistical analyses 
Data were tested for normality using the D’Agostino-Pearson omnibus normality test, or 
the Kolmogorov-Smirnov test when the sample was small due to experimental conditions. 
Differences between means were tested by Student’s t test for normal data, whereas non-normal 
data were analyzed by the Mann-Whitney test. Data from multiple groups were analyzed by 
ANOVA followed by Newman-Keuls multiple comparison test. 
All values were expressed as the mean ± s.e.m. Samples were analyzed using Student’s 
t-test for two groups and ANOVA for multiple groups. For in vitro experiments, statistical 
analyses were calculated with a paired Student’s t-test; for in vivo experiments, differences 
between groups were calculated using the Mann–Whitney U test for unpaired data (GraphPad 
Prism version 5.0). Differences were considered significant when * p ≤ 0.05, **p ≤ 0.01, ***p ≤ 
0.001. 
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4. RESULTS 
 
4.1 T cell activation promotes mitochondrial translocation toward the pSMAC 
 We first assessed the precise localization of mitochondria during IS formation by confocal 
microscopy of Jurkat T cells conjugated with superantigen-E (SEE)-pulsed Raji cells or 
hemagglutinin peptide (HA)-pulsed HOM2 B cells as antigen-presenting cells (APC). In both 
experimental systems of cell activation, most T cell mitochondria moved in an orchestrated 
manner toward the IS, where the microtubule-organizing center (MTOC) and the TCR/CD3 
cluster were situated (Figure R1A-C). These synaptic mitochondria surrounded the central 
TCR/CD3 cluster and were located beneath the actin ring at the pSMAC (Figure R1D and R1E). 
     
 
Figure R1. Mitochondria translocate toward the pSMAC upon T cell activation. (A) J77 T cells loaded 
with Mitotracker Orange (red) were conjugated with unpulsed or SEE-pulsed Raji B cells loaded with 
CMAC (blue). Cells were stained with anti-CD3 or tubulin-FITC (green) to reveal TCR clustering and 
MTOC orientation. (B) Analysis as in A of HA-specific CH7C17 T cells conjugated with unpulsed or HA-
pulsed Hom2 APCs. Scale bars, 10 μm. (C) Mitochondrial accumulation at the IS of conjugates stimulated 
as in A and B. (D,E) Maximum projection of a confocal Z-stack of conjugates stimulated as in A. Cells 
were stained with CD3 Ab (D) or phalloidin (green) (E) to determine the areas of the cSMAC and pSMAC. 
Right panels show maximal projection of 3D-reconstructions from the IS. Scale bars, 5 μm.  
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The kinetics of mitochondria translocation during IS formation was studied in human 
primary T lymphoblasts plated onto planar lipid bilayers containing GPI-linked ICAM-1 and anti-
human CD3 antibody. CD3 microclusters appeared early at the periphery of the IS structure, and 
then moved centripetally to form the cSMAC (Figure R2A). Simultaneously with the 
redistribution of CD3 to form a central cluster, mitochondria spread near the cell-bilayer interface 
during the first 3 min after plating and then relocated toward the pSMAC to form a ring around 
the TCR/CD3 central cluster (Figure R2A and R2B). This mitochondrial reorganization was also 
analyzed by total internal reflection fluorescence microscopy (TIRFM), revealing movement of 
mitochondria from the periphery of the contact area toward the center of the IS (Figure R2C). 
Although some mitochondria appeared to move in and out of the cSMAC, most were localized at 
the pSMAC. These results indicate that during the formation of the IS mitochondria relocate to 
form a ring-shaped structure at the pSMAC of the IS. 
 
 
Figure R2.  Mitochondria move centripetally toward the pSMAC. (A) Migration of mitochondria 
toward the IS in mitotracker-preloaded human T lymphoblasts adhered to GPI-linked ICAM-1 and anti-
CD3-containing lipid bilayers. CD3 clusters (green) and mitochondria (red) were detected by confocal 
microscopy at the indicated times on a single confocal plane. Scale bar, 5 μm. (B) Fluorescence intensity 
profiles from A show the pSMAC localization of mitochondria at the indicated times. (C) TIRF microscopy 
of mitoYFP expressing T cells plated on a CD3 plus CD28 Ab surface. Magnified views show forward-
backward movement of a mitochondrion at the edge of the contact with the activating surface. Scale bar, 1 
μm. 
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4.2 Drp1 regulates mitochondrial positioning at the Immune Synapse (IS) and IS 
architecture 
The mitochondrial fission factor Drp1 is a key component of the mitochondrial dynamics 
machinery (Chen et al., 2010). Previous studies showed that dissociation of Drp1 from 
mitochondria occurs concomitantly with mitochondrial mislocalization (Varadi et al., 2004), 
suggesting that Drp1 may play a role in mitochondrial redistribution and positioning in highly 
polarized cells. We therefore studied whether, in response to antigen-pulsed APC, Drp1 associates 
with mitochondria in T cells and enables their translocation and positioning at the IS. Double 
immunofluorescence microscopy analysis showed that Drp1 localized with mitochondria at the 
IS of T cells conjugated with SEE- or HA-pulsed APC (Figure R3A-C). Accordingly, cell 
fractionation analysis confirmed recruitment of Drp1 to mitochondria in antigen-specific T cell-
APC conjugates (Figure R3D and R3E) but not in the absence of antigen (not shown). 
           
Figure R3. Drp1 is recruited to mitochondria upon T cell-APC conjugates. Immunofluorescence 
localization of Drp1 (green) in mitotracker-loaded T cells (red) conjugated with unpulsed or antigen-loaded 
APCs (CMAC-loaded, blue): (A) J77 T cells plus SEE-pulsed Raji B cells; (B) CH7C17 T cells plus HA-
pulsed Hom2 cells. (C) Endogenous accumulation of Drp1 at the IS in T cell-APC conjugates. Maximum 
projections of a confocal Z stack were quantified. Data are means  s.d. of 60 conjugates from two 
independent experiments. (D,E) Time course of Drp1 content in the mitochondrial fractions of APC-
activated J77 and CH7C17 T cells. MnSOD was used as mitochondrial marker.  
 
To determine whether Drp1 drives the redistribution of mitochondria toward the IS, we 
silenced Drp1 expression in J77 T cells using Drp1-specific siRNAs (Figure R4A) and studied 
the localization of their mitochondria in antigen-specific conjugates with APC. Mitochondrial 
translocation towards the IS was reduced in Drp1 knockdown J77 T cells stimulated with SEE-
pulsed Raji B cells (Figure R4B and R4C). Interestingly, under these experimental conditions, 
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MTOC translocation was unaffected (Figure R4C). The expression of YFP-fused wild-type Drp1 
(Drp1WT-YFP) in Drp1 knockdown J77 T cells restored SEE-dependent mitochondrial 
translocation (not shown), confirming that Drp1 silencing specifically interfered with this process. 
 
Figure R4. Drp1 regulates mitochondrial positioning at the IS. (A) Western blot analysis of siRNA 
Drp1 silencing in J77 T cells after 48 h. (B) Confocal localization of mitochondria (mitotracker, red), 
MTOC (tubulin, green) and endogenous Drp1 (purple) in J77 T cells conjugated with Raji B cells (CMAC-
loaded, blue). Scale bar, 10 μm. (C) Mitochondrial accumulation and MTOC positioning at the IS. Data in 
C represent means ± s.d. of 60 conjugates from three experiments (p<0.05, Mann Whitney test).  
        
The above results suggest that Drp1 regulates mitochondrial localization directly by acting on 
mitochondria dynamics. To assess this, we uncoupled Drp1 from mitochondria by two 
approaches: overexpression of a phosphomimetic S637D mutant of Drp1 (Drp1S637D-YFP) or 
treatment of cells with mitochondrial division inhibitor-1 (mdivi-1). These approaches prevent 
Drp1 docking at the mitochondrial outer membrane and consequently reduce mitochondrial 
fission (Cassidy-Stone et al., 2008; Cereghetti et al., 2008; Tanaka and Youle, 2008). Expression 
of Drp1S637D-YFP reduced SEE-induced mitochondrial redistribution compared with 
overexpression of Drp1WT-YFP or a non-phosphorylable Drp1 mutant (Drp1S637A-YFP) (not 
shown). Similar results were obtained when T cells were treated with mdivi-1 (Figure R5A and 
R5B). Transmission electron microscopy (TEM)-based morphometric studies of T cell-APC 
conjugates revealed that mitochondria in mdivi-1-treated cells were farther from the IS and were 
enlarged in area and perimeter compared with control cells (Figure R5C and R5D).  
 65 
 
Results 
        
 
 
To determine whether Drp1-mediated mitochondrial redistribution and positioning at the 
pSMAC is important for IS organization, we studied the effect of Drp-1 silencing on CD3 
assembly at the cSMAC. Although Drp1 knockdown did not alter the expression levels of CD3 
or LFA-1 on the plasma membrane of J77 T cells (data not shown), the central clustering of 
TCR/CD3 at the IS was inhibited (Figure R6A and R6B). 3D-reconstruction of the IS formed by 
Drp1-silenced J77 cells and SEE-pulsed APCs revealed a scattered distribution of CD3, an 
enlarged cSMAC diameter and an increased number of CD3 clusters (Figure R6C-6F). 
Consistently, in planar lipid bilayer assays, Drp1-silenced cells did not form a cSMAC, and CD3 
microclusters were unable to coalesce at the center of the IS. In these cells, in contrast with control 
cells, mitochondria did not relocate to the IS and did not form a ring-shaped structure around the 
Figure R5. Drp1-mediated mitochondrial fission regulates translocation of mitochondria toward the IS. (A) 
Confocal localization of mitochondria (MnSOD, red) in J77 conjugated with Raji B cells (CMAC-loaded, blue) under 
the indicated treatments. Scale bar, 10 m. (B) Mitochondria accumulation at the IS (248 control and 100 mdivi-1-
treated conjugates, *** p<0.001. (C) Transmission electron microscopy images from J77-Raji B cell conjugates. 
Right, magnified views of mitochondria. (D) Mitochondria distance to the IS and morphometric analysis (109 
mitochondria in ten control conjugates and 89 mitochondria from seven mdivi-1–treated conjugates, * p<0.05). 
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cSMAC (not shown). These results indicate that Drp1 plays an important role in the formation of 
the IS, linking mitochondrial positioning to the molecular organization of CD3 at the cSMAC. 
      
 
4.3 Mitochondria depolarize at sites of TCR activation 
To explore the mechanism by which Drp-1-mediated mitochondrial redistribution 
regulates cSMAC assembly, we assessed mitochondrial function and energy status in activated T 
cells. We first monitored mitochondrial membrane potential (Δψm) by time-lapse confocal 
microscopy of J77 T cells expressing MitoYFP and labeled with the potentiometric dye TMRM. 
When these cells were plated onto CD3/CD28 Ab activating surfaces, the mitochondria closest to 
the bottom surface abruptly depolarized as indicated by the drop in TMRM fluorescence (Figure 
R7A), whereas plating onto poly-L-lysine plus control Ab had no effect (not shown). These results 
were confirmed by flow cytometry of whole cell populations labeled with the mitochondria-
specific cation tracker JC-1. The JC-1 emission maximum at high Δψm is 590 nm (red, detected 
in FL2) and shifts to 520 nm (green, detected in FL-1) as Δψm decreases (Solaini et al., 2007). 
Figure R6. Drp1 controls IS organization. (A) Distribution of Drp1 (red) and CD3 (green) in J77 T 
cells conjugated with Raji B cells (CMAC-loaded, blue). Scale bar, 10 μm (B) CD3 accumulation at the 
IS calculated from maximal confocal Z projections (p<0.0001, Mann Whitney test) (C) 3D 
reconstructions of the cell-cell contact area in J77-APC conjugates. Scale bar, 5 μm. (D) Profile plot of 
CD3 (green) and mitochondria (red) in the structures depicted in C. (E,F) CD3 diameter and cluster 
number calculated from 3D reconstructions of T cell-APC contacts. Data are means  s.d from three 
independent experiments, p<0.001, Student’s t test. 
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Using this label, we found that CD3/CD28 engagement diminished Δψm in human primary T 
lymphoblasts whereas mitochondrial depolarization was significantly enhanced in Drp1-silenced 
cells, even in the absence of stimulation (Figure R7B and R7C).  
 
 
4.4 Drp1 regulates myosin fueling at the IS 
We next assessed the effect of CD3/CD28 engagement on T lymphoblast intracellular 
ATP levels. ATP content increased in activated T cells with respect to untreated cells, an effect 
reverted by the mitochondrial ATP-synthase inhibitor oligomycin (not shown). In contrast, 
CD3/CD28 stimulation did not significantly change ATP levels in Drp1-interfered cells (not 
shown). Mitochondrial membrane potential and ATP production are thus compromised in Drp1 
silenced T cells during activation, suggesting a role for Drp1 in the regulation of IS organization 
through the control of mitochondrial function. To test this possibility, T cells were treated with 
the mitochondrial uncoupling agent FCCP (which abolishes ψm), the ATP synthase inhibitor 
oligomycin, or the mitochondrial fission inhibitor mdivi-1. Treatment of SEE-specific T cell-APC 
conjugates with any of these agents inhibited clustering of CD3 at the IS to a similar extent as 
Drp1 silencing (Figure R8A and R8B), thus linking Drp1-dependent mitochondrial function and 
depolarization to IS organization. 
Figure R7. Mitochondria depolarize 
at sites of TCR activation. (A) Time-
lapse confocal microscopy of 
mitoYFP-J77 T cells loaded with 
TMRM and plated on anti-CD3/CD28 
coated coverslips. Profile plots show 
variations in fluorescence intensity in 
the indicated mitochondria (regions of 
interest, ROI). (B,C) JC-1 flow 
cytometry analysis of mitochondrial 
membrane potential (FL2 vs. FL1) in 
human T lymphoblasts. Percentage of 
cells with depolarized mitochondria 
(blue) is indicated. Data are means ± 
s.d. from four donors (* p<0.05). 
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 Consistent with these results, myosin activation, an ATP-dependent process involved in IS 
formation (Ilani et al., 2009), was impaired in Drp1-silenced T lymphoblasts and J77 cells, which 
showed lower levels of myosin regulatory light chain (MLC) phosphorylation at Ser19 than 
control cells (Figure R9A and R9B). MLC phosphorylation in SEE-specific T cell-APC 
conjugates mostly took place at the IS of control T cells, and was strongly reduced by Drp1 
silencing (Figure R9C and R9D). Given that phosphorylation of MLC at Ser19 increases the 
motor activity of myosin (Huttenlocher et al., 1995), and that myosin IIA localizes at the IS of T 
cells (Ilani et al., 2009), our results strongly suggest that ATP-dependent myosin contractile 
activity is diminished at the IS of Drp1-silenced T cells. Together these results support that Drp1 
regulates mitochondrial-dependent myosin fueling at the IS by impeding persistent mitochondrial 
depolarization and thereby favoring ATP synthesis. 
Figure R8. Mitochondrial depolarization impairs TCR clustering at the IS. (A) Confocal 
analysis of CD3 organization (green) in conjugates formed by control, Drp1-silenced, or J77 T 
cells treated with mdivi-1, FCCP, oligomycin or vehicle. SEE-pulsed Raji B cells, CMAC 
(blue). Scale bar, 10 m. (B) CD3 maximum diameter in J77 T cells conjugated as in A: The 
numbers of conjugates analyzed 409 (control), 136 (siDrp1), 313 (midiv-1), 339 (FCCP) and 
230 (oligomycin). Data are means  s.d from three independent experiments (*** p<0.001). 
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4.5 Drp1 modulates TCR signal strength  
We next assessed the role of Drp1 in TCR/CD3 signaling. Microclusters of tyrosine-
phosphorylated proteins were peripherally distributed in the IS of Drp1-silenced T cell-APC 
conjugates, contrasting with their concentration at the cSMAC in control conjugates (Figure 
R10A). Drp1 silencing provoked dispersal of the phospho-ERK signal at the SEE-dependent IS 
(Figure R10B) and a longer-lasting phosphorylation of ERK1/2 and PLC-1 in SEE stimulated 
primary T lymphoblasts and J77 T cells (Figure R10C and R10D). Moreover, Ca2+i flux was also 
maintained for longer in Drp1-silenced J77 T cells upon conjugation with SEE-pulsed Raji APCs 
(not shown). Finally, Drp1 silencing increased the secretion of IL-2 in SEE-dependent T cell-
APC conjugates (not shown). These results suggest that Drp1 modulates TCR proximal signaling 
and IL-2 production through the control of mitochondria positioning and activity at the IS. 
Figure R9. Drp1 regulates myosin fueling at the IS. Phosphorylation of MLC at Ser 19 in 
conjugates formed between human T lymphoblasts (A) or J77 T cells (B) and SEE-pulsed Raji B cells. 
MLC and tubulin are shown as loading controls. (C) Confocal analysis of pMLCSer19 (green) and 
actin (red) in J77 T cells conjugated with Raji B cells (CMAC, blue). 3D stack reconstructions show 
pMLCSer19 and the actin ring at the T cell-APC contact site. (D) pMLCSer19 accumulation at the IS 
in SEE-specific conjugates. Data are means  s.d from two independent experiments (*** p<0.001).  
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4.6 Tfam depletion induces a respiratory-chain deficiency in T cells 
The requirement for mitochondrial function in fueling T cell activation prompted us to 
further investigate the mechanisms by which mitochondria regulate immune responses. We 
generated a mouse model specifically lacking Tfam in CD4+ T cells by crossing mice with loxP-
flanked Tfam alleles with CD4+Cre mice. Consistent with gene deletion in the early stages of T 
cell development, Tfam deletion efficiently decreased the mRNA of Tfam in CD4+ and in CD8+ 
T naive lymphocytes (not shown). CD4+Cre+/wtTfamfl/fl mice (herein Tfam-/- mice) developed 
normally and showed similar frequency of double negative and double positive thymocytes to 
their control littermates (Figure R11A), indicating that Tfam is not required during early T cell 
development. Tfam-/- mice presented slightly lower percentages of CD4+ and CD8+ T cells in the 
spleen and peripheral lymph nodes, but had similar numbers of total splenocytes, B cells and 
dendritic cells to littermate CD4+Crewt/wtTfamfl/fl controls (herein wild-type mice, wt) (Figure 
R11B and not shown).  
Figure R10. Drp1 regulates TCR signal strength. Confocal 3D stack reconstructions showing the 
distribution of phosphotyrosine (pY) (A) and phosphorylated ERK1/2 (B) at the contact site between 
mitotracker-loaded J77 T cells and SEE-pulsed Raji B cells (asterisks). Time course of the phosphorylation 
status of PLC-γ1 and ERK 1/2 in control and Drp1-silenced human primary lymphoblast T cells (C) or J77 
T cells (D) activated with SEE-pulsed Raji B cells. Tubulin or total protein expression are shown as loading 
controls. Immunoblots are representative of three independent experiments 
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Naive Tfam-/- CD4+ T cells expressed comparable levels of specific T cell surface markers 
to wild-type cells and responded normally to in vitro differentiation toward T lymphoblasts, 
adopting a polarized morphology (Figure R12A and R12B). The levels of Tfam were efficiently 
suppressed throughout lymphoblast differentiation, excluding the selection of Tfam-positive cells 
during in vitro expansion (Figure R12C).  
 
Figure R11. Tfam depletion does not 
impact T cell development. (A) Dot 
plots show CD4 and CD8 expression in 
thymocytes from wt and Tfam-/- mice. 
Right, percentage of CD4 and CD8 single 
positive (SP), and CD4/CD8 double 
positive (DP) cells. (B) Dot plots show 
CD4 and CD8 T cells, and CD3 and B220 
cells from the spleens. Right, percentages 
of CD4 and CD8 cells in the spleen, 
inguinal (ILN) and mesenteric lymph 
nodes (MLN) (n=11). 
 
Figure R12. Tfam depletion does not impact T 
cell blastogenesis. (A) Flow cytometry analysis of 
cell surface markers in T-lymphoblasts 
differentiated with concanavalin A (ConA, 48h) and 
IL-2 over 4 days. (B) Immunofluorescence images 
show the polarized organization of cytoskeletal 
components in wt and Tfam-/- CD4+ T lymphoblasts 
by actin, tubulin and ERM (ezrin-radixin-moesin) 
staining. (C) Tfam mRNA levels in naive CD4+ T 
cells (day 0) and during lymphoblast differentiation. 
Tfam mRNA (center) and protein levels (right) in 
wild-type and Tfam-/- CD4+ T lymphoblasts. 
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Consistent with the close relationship between levels of Tfam and mtDNA (Ekstrand et 
al., 2004; Larsson et al., 1998), lack of Tfam induced a severe decrease in mtDNA content, both 
in Tfam-/- CD4+ T lymphoblasts and in human Jurkat T cells stably transfected with Tfam short 
hairpin RNAs (shTfam) (Figure R13A). Tfam deficiency reduced the mRNA expression of 
mtDNA-encoded subunits of mitochondrial complexes I, III, IV and V, whereas nuclear-encoded 
subunits were not significantly affected (Figure R13B). Consistently, the protein levels of 
complexes I and IV, which include mtDNA-encoded subunits, were below normal, whereas the 
fully nuclear-encoded complex II was unaffected (Figure R13C).  
 
In response to these respiratory-chain alterations, Tfam-deficient cells increased 
mitochondrial content (Figure R14). However, electron microscopy analysis revealed severely 
aberrant mitochondrial morphology in Tfam-/- CD4+ T cells, accompanied by impaired cristae 
organization and loss of mitochondrial electron density (Figure R15), consistent with a 
mitochondrial dysfunction caused by depletion of Tfam in T cells. 
  
 
Figure R13. Tfam deletion decreases mtDNA. (A) mtDNA levels relative to genomic DNA in T 
lymphoblasts. (B) mRNA levels of mtDNA-encoded and genome-encoded mitochondrial subunits. 
Results (A, B, C) are expressed relative to wt. (C) Immunoblot of T lymphoblast mitochondrial 
proteins. Protein levels of Complex I (CI) were immunodetected with anti-NDUFA9, CII with anti-
FpSDH, and CIV with anti-CO1. The mitochondrial outer membrane protein Tom20 was used as 
loading control. Data (A, B, C) are means ± SEM (n > 3); *p<0.05, **p<0.01 and ***p<0.0001 
(Student’s t-test).  
 
Figure R14. Abnormal mitochondrial 
morphology in Tfam-deficient cells. Confocal 
images of mitochondria (anti-MnSOD, green) in T 
lymphoblasts. Right, flow cytometry analysis of 
mitochondrial mass by Mitotracker green mean 
fluorescence intensity ± SEM of three independent 
experiments; *p<0.05 (Student’s t-test).  
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We next studied the effect of Tfam silencing on the assembly of mitochondrial complexes 
(Lapuente-Brun et al., 2013). Blue native gel electrophoresis (BNGE) of extracts from Tfam-
silenced cells revealed severe loss of complexes I and III but not II, and associated alterations in 
mitochondrial supercomplex assembly (Figure R16A). Accordingly, Tfam-depleted cells showed 
stronger impairment of electron transport from NADH (complexes I+III) than from FADH2 
(complexes II+III) (Figure R16B), demonstrating an imbalance in the NAD+/NADH ratio in 
respiratory-chain deficient cells, as described for cells with mutations in mitochondrial complex 
I subunits (Santidrian et al., 2013). Connected with the reduced electron transport chain function, 
Tfam-deficient T cells also had below-normal content of mitochondrial reactive oxygen species 
(ROS) assessed by MitoSOX (Figure R16C), and reduced mitochondrial ATP generation (Figure 
R16D). Despite the effect on mitochondrial ATP production, total cellular ATP content in primary 
CD4+ Tfam-/- T cells and Jurkat shTfam T cells was comparable with controls (Figure R16E and 
not shown). In addition, the phosphorylation level of the metabolic sensor AMP-activated protein 
kinase (AMPK) (Hardie et al., 2012) did not differ between Tfam-deficient and control cells 
(Figure R16F), indicating that global energy status is not compromised in Tfam-depleted cells. 
 
Figure R16. Tfam deletion decreases mitochondrial 
function in T cells. (A) Blue-native gel electrophoresis 
analysis of electron-transport-chain complexes 
(detection of NDUFA9, FpSDH and Core1 for 
complexes I, II and III, respectively). (B) Combined 
mitochondrial complex activities. (C) Flow cytometry 
analysis of mROS (MitoSOX). (D) Glutamate- and 
pyruvate-driven ATP-dependent production. (E) Cellular 
ATP content. (F) Immunoblot analysis of AMPK 
phosphorylation at Thr172 in T lymphoblasts. Actin was 
used as a loading control. 
Figure R15. Abnormal 
mitochondrial cristae in Tfam-
deficient cells. Electron 
microscopy images showing 
enlarged mitochondria and altered 
cristae organization in Tfam-/- 
CD4+ T lymphoblasts. 
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We then analyzed the metabolic consequences of Tfam deletion on CD4+ T cells by flux 
analysis. In activated CD4+ T cells, we measured the extracellular acidification rate (ECAR), as 
an index of lactate production and glycolysis, and the oxygen consumption rate (OCR) as an 
indicator of mitochondrial oxidative phosphorylation (OXPHOS). Upon activation with anti-CD3 
and anti-CD28, wild-type T cells used glycolysis and OXPHOS for glucose consumption, as 
described (Michalek et al., 2011a; van der Windt and Pearce, 2012; Wang et al., 2011). In contrast, 
Tfam-/- T cells presented a low OCR and an ECAR above wild-type levels, demonstrating 
anaerobic glucose utilization (Figure R17). Additionally, we examined mitochondrial fatty acid 
ß-oxidation (FAO) in respiration-deficient cells. Naive wild-type and Tfam-/- CD4+ T cells were 
activated over 48h and then incubated with fatty acids prior to flux analysis. In these conditions, 
activated wild-type CD4+ T cells showed increased OXPHOS and reduced glycolysis (Figure 
R17), thus relying on fatty acid ß-oxidation and mitochondrial OXPHOS for energy production. 
In contrast, Tfam-/- T cells showed severely reduced OCR, supporting the conclusion that FAO is 
impaired in respiratory-chain deficient cells (Figure R17).  
 
Tfam deletion thus promotes loss of mtDNA, mitochondrial oxidative phosphorylation 
(OXPHOS) deficiency, and compromised mitochondrial function, but has no significant impact 
on cellular energy status or survival. Additionally, mitochondrial respiration deficiency induces a 
metabolic reprogramming characterized by increased anaerobic glucose consumption and 
impaired fatty acid oxidation. 
 
Figure R17. Tfam deletion imposes a 
metabolic switch. Spleens and lymph nodes 
were harvested from wild-type and Tfam-/- 
mice and naive CD4+ T cells were isolated 
by negative selection using magnetic 
separation and activated for 48h with anti-
CD3 and anti-CD28. Cells were fed either 
with glucose or the fatty acid palmitate for 2 
hours and the oxygen consumption rate 
(OCR) and extracellular acidification rate 
(ECAR) were measured in real time (upper 
panels). Lower panels show the basal OCR 
and ECAR from a representative 
experiment. 
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4.7 Tfam deficiency exacerbates inflammatory responses 
We next assessed how these mitochondrial alterations caused by Tfam deficiency affect T cell 
effector function. Upon T cell activation, Tfam expression increased concomitantly with an 
increase in mtDNA levels (Figure R18A), suggesting that mitochondrial adaptation to T cell 
activation requires an increase in mtDNA levels. We then determined the functional consequences 
of Tfam deletion during T cell activation and acquisition of effector functions. 
T cells from wild-type and Tfam-/- mice were labeled with the proliferation indicator Cell 
Violet, stimulated with anti-CD3 and anti-CD28 antibodies, and evaluated by flow cytometry. 
Tfam-/- T cells showed reduced proliferation (Figure R18B). Moreover, upon in vitro cell 
activation, there was no evidence of higher apoptosis in Tfam-/- T cells, as assessed by flow 
cytometry analysis of annexin V and H58 staining (not shown). CD4+ Tfam-/- cells showed similar 
levels of the activation markers CD69 (very early activation antigen) and CD25 (IL-2Ralpha) 
(Figure R18C). Stimulated Tfam-/- CD4+ T lymphocytes showed increased numbers of IFN-γ- and 
T-bet-producing cells compared to wild-type cells (Figure R18D). RT-PCR analysis indicated 
strikingly elevated mRNA expression of the pro-inflammatory cytokines IFN-γ, IL-6, IL-1α and 
IL-1β and increased IFN-γ and IL-6 secretion were detected in the supernatant of Tfam -/- T cells 
(Figure R18E). In contrast, mRNA levels and cytokine secretion of IL-4 and IL-10 were below-
normal in Tfam-deficient cells (Figure R18F). These in vitro data highlight the requirement on 
mitochondrial function for the fine regulation of T cell responses. 
  
Figure R18. Inhibition of OXPHOS 
exacerbates inflammatory responses. (A) 
mtDNA content and Tfam mRNA levels in 
naive and anti-CD3/CD28 activated T cells 
(48h). Results expressed relative to 
unstimulated naive T cells. (B) Cell 
proliferation in T cells stained with Cell Violet. 
(C) Flow cytometry analysis of CD69 and 
CD25 in activated T cells. (D) Intracellular 
IFN- and T-bet levels. (E) Left, IFN- levels in 
the supernatant measured by ELISA. Right, 
IFN- mRNA levels. (F) IL-4, IL-6 and IL-10 
levels in the supernatant measured by ELISA. 
Data are means ± SEM of at least 3 independent 
experiments; *p<0.05, **p<0.01, ***p<0.0001 
(Student’s t-test). 
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To assess the role of mitochondria in the regulation of the inflammatory function of T cells in 
vivo, we first examined a model of contact hypersensitivity (CHS), which is mainly mediated by 
IFN-γ. The specificity of the CHS response is generally defined as the difference between ear 
swelling responses to a hapten such as oxazolone in naive and sensitized animals. Upon 
sensitization to oxazolone, Tfam-/- mice showed larger increases in ear thickness, lymph node 
cellularity, and IFN-γ-producing CD4+ T lymphocytes (Figure R19A). In addition, we performed 
a model of DSS-induced colitis, which is driven by Th1 and Th17 cells and suppressed by Treg 
cells. Wild-type mice and Tfam-/- mice were fed with DSS to induce gut damage and trigger 
disease. Tfam-/- mice showed increased disease severity, as reflected by higher weight loss over 
time, increased disease score and shorter colon length than wild-type mice (Figure R19B-E). 
Remarkably, Tfam-deficiency increased the frequency of IFN-γ- and T-bet-expressing CD4+ T 
cells in the mesenteric lymph nodes upon DSS-treatment (Figure R19F and not shown). These 
results indicate that respiration-impaired T cells develop a stronger inflammatory response in vitro 
and in vivo and support a critical role for mitochondria in the regulation of T cell effector functions 
during immune responses. 
 
 
  
 
Figure R19. Tfam depletion exacerbates 
inflammatory responses in vivo.  (A) 
Left, ear thickness upon oxazolone re-
challenge. Center, cell number in the 
lymph nodes. Right, IFN--producing 
CD4+ T cells in the challenged ear lymph 
nodes. (B) Weight and (C) disease score in 
mice fed with 3% dextran sulfate sodium 
(DSS) in the drinking water. (D) 
Representative H&E staining of colon 
sections and colon length (E) on day 7 
after DSS treatment. (F) IFN--producing 
CD4+ T cells in the mesenteric lymph 
nodes. Data (B-F) are means ± SEM (n ≥ 
7 mice in two independent experiments); 
*p<0.05, **p<0.01 and ***p<0.0001 
(Student’s t-test). 
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4.8 Mitochondrial dysfunction deviates T cell differentiation toward pro-
inflammatory Th1 subsets 
To provide further insights into how mitochondrial function controls T cell differentiation, we 
assessed the ability of Tfam-deficient T cells to differentiate into effector T cell subsets. The 
balance among different functional effector T cell subsets determines the outcome of the immune 
response and is essential to prevent undesired inflammation and autoimmune diseases. Naive 
CD4+ T cells were labeled with Cell Violet, differentiated in vitro with different cytokines and 
neutralizing antibodies to Th1, Th2 and Th17 T cell subsets, and assessed for proliferation and 
expression of specific transcription factors and cytokines. Tfam deficiency greatly impaired 
proliferation in all the skewing conditions (Figure R20A and R20C), thus indicating a reliance on 
mitochondrial function in all the polarizations tested. Tfam-depleted cells showed higher 
expression of the Th1-specific transcription T-bet, higher numbers of IFN-γ-producing cells and 
higher levels of IFN-γ secretion (Figure R20A and R21). In all polarization conditions, Tfam-/- 
CD4+ T cells secreted less IL-4 than wild-type cells (Figure R21), demonstrating a Th1/Th2 
imbalance toward the Th1 response in the absence of Tfam.  
                  
Figure R20. Mitochondrial dysfunction subverts T cell differentiation toward Th1 cell subsets. (A) Cell Violet 
dilution and T-bet expression in CD4 T cells cultured under Th1 and Th2 conditions over 3 days. Chart, percentage of 
T-bet expressing cells (n=3). (B) Flow cytometry analysis of IFN--producing cells under Th1 and Th2 conditions over 
6 days. Graph, quantification of IFN--producing cells (n=6). (C) Naive CD4 T cells were cultured under Th17 and Treg 
conditions over 3 days. Dot plots show RORT-expressing cells and histograms show cell proliferation assessed by Cell 
Violet dilution. Chart, percentage of RORT-expressing cells (n=3). (D) Flow cytometry analysis of CD4 T cells 
producing IL-17 and Foxp3. Chart shows percentage of IL-17 and Foxp3-producing cells (n=6). Data are means ± SEM 
(n ≥ 3); *p<0.05 and ***p<0.001 (Student’s t-test). 
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When polarized toward Th17 T cell subset, no substantial differences were found in the 
number of RORt-expressing cells between Tfam-/- and wild-type cells (Figure R20C). However, 
impaired mitochondrial function in Tfam-/- CD4+ T cells significantly reduced the levels of IL-17-
producing cells and impaired IL-17 and IL-10 secretion, while increasing the frequency of IFN-
γ-producing cells and IFN-γ secretion (Figure R20D and R21). Thus, Tfam-deficiency favoured 
the appearance Th17 cells which coexpress RORγt and T-bet, and produce high levels of IFN-γ 
but reduced amounts of IL-10, and which have been proposed to be pathogenic Th17 cells 
involved in autoimmune diseases in mice (Huber et al., 2011; Peters et al., 2011). Collectively, 
these results reveal a role for mitochondrial function in the regulation of T cell differentiation and 
indicate that mitochondrial dysfunction is associated with a deregulation of T cell differentiation 
toward pro-inflammatory Th1 cell subsets.  
 
Figure R21. Tfam depletion induces Th1 cytokine profile. Polarized CD4+ T cells at day 6 were cultured 
in equal numbers in fresh medium followed by activation with PMA/ionomycin for 16h. Cytokines were 
measured by ELISA in the supernatants. Graphs show quantification of IFN-, IL-4, IL-17 and IL-10 in at 
least 4 independent experiments. *p<0.05, ***p<0.0001 (Student’s t-test). 
 
4.9 Mitochondrial oxidative phosphorylation is required for exosome secretion through reactive 
oxygen species signaling 
In addition to the profound morphological and functional mitochondrial alterations, electron 
microscopy studies revealed striking intracellular vesiculation in Tfam-deficient cells (Figure 
R22A). These abnormalities prompted us to explore the role of mitochondria in the regulation of 
the endolysosomal system. We investigated the abundance and organization of the endosomal 
compartment in Tfam-deficient cells. The early endosome marker EEA1 showed no substantial 
differences, but expression of the late endosomal markers HRS and the lysobisphosphatidic acid 
(LBPA) was elevated in respiratory-chain deficient cells (Figure R22B). LBPA, an 
unconventional phospholipid specifically found in late endosomes and MVBs, regulates 
intraluminal vesicle (ILV) formation during exosome biogenesis (Matsuo et al., 2004). 
Immunofluorescence analysis with an antibody against LBPA revealed enlargement of late 
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endosome/multivesicular bodies (MVBs) in Tfam-deficient cells (Figures R22C) and in shTfam 
Jurkat T cells (Figures R22D). Strikingly, electron microscopy analysis of Tfam-deficient T cells 
revealed enlarged late endosomes with decrease numbers of ILVs (Figure R22E), suggesting 
impaired MVB maturation. 
 
 
To determine the impact of Tfam depletion on the regulation and maturation of the late 
endosomal compartment, we analyzed exosome secretion. Exosomes were purified by serial 
ultracentrifugation from equal numbers of control and Tfam-deficient cells. Tfam-silenced cells 
secreted 30-40% fewer nanoparticles than control cells, quantified by nanoparticle tracking 
analysis (NTA) (Figure R23A). Exosomes obtained from shTfam-silenced Jurkat T cells had a 
significantly below-normal protein content of the exosomal markers CD63, CD81, CD9, and 
ERMs (Figure R23B), a reduction also confirmed in primary Tfam-/- T lymphoblasts (Figure 
R23B). In addition, Tfam-silenced cells showed decrease exosome secretion in response to PMA 
 Figure R22. Tfam regulates multivesicular body maturation. (A) Electron microscopy images show the 
abnormal intracellular accumulation of vesicles in Tfam-/- T cells. (B) Flow cytometry analysis of EEA1, HRS 
and LBPA content in CD4+ T lymphoblasts. Results show mean fluorescence intensity (m.f.i.) from three 
independent experiments. *p<0.05 (Student’s t-test). (C) Confocal detection of HRS and LBPA in T 
lymphoblasts. Nuclei were stained with HOECHST (blue). (D) Immunofluorescence analysis of LBPA in 
Jurkat T cells. (E) Electron microscopy images from wild-type and Tfam-/- T lymphoblasts. 
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and ionomycin (not shown), indicating that constitutive and activation-induced exosome release 
is compromised in respiration-impaired cells. Sucrose gradient characterization of exosomes 
derived from Tfam-silenced cells showed low levels of the exosomal markers CD63, CD81 and 
ERMs in the fractions corresponding to the density of exosomes (Figure R23C). Lack of Tfam 
thus induces a respiration deficiency associated with enlarged LBPA-positive MVBs and 
decreased biogenesis and secretion of exosomes. These data reveal an unanticipated link between 
mitochondrial function and regulation of exosome secretion. 
 
 
 
 
To investigate the impact of cell metabolism in the regulation of exosome secretion, we treated 
wild-type T cells with dichloroacetate (DCA), which shifts metabolism from glycolysis toward 
OXPHOS by inhibiting pyruvate dehydrogenase kinase (PDK). PDK inhibition activates pyruvate 
dehydrogenase (PDH), promotes pyruvate mitochondrial oxidation and reduces lactate secretion. 
Figure R23. Tfam regulates exosome secretion. (A) Number of released extracellular vesicles obtained from equal 
numbers of Jurkat T cells and quantified by nanoparticle tracking analysis (NTA). Data are means ± SEM of three 
independent experiments. *p<0.05 (Student’s t-test). (B) Upper panel, protein immunoblot of the exosomal proteins 
ERMs, CD63, CD81 and CD9, detected in the exosome fraction of Jurkat T cells. Lower panel, purified exosomes 
secreted by primary CD4+ T lymphoblasts and immunoblotted for the exosome markers CD81 and TSG101. (C) 
Western blot showing enrichment of the exosome markers CD81, CD63 and ERMs in sucrose fractions. Exosomes 
were laid on top of discontinuous sucrose gradient and floated by overnight centrifugation. Gradient fractions were 
collected and analyzed by immunoblot to show the distribution of exosomal proteins in the sucrose fractions from 
lower (left) to higher sucrose densities (right). 
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Treatment of wild-type T lymphoblasts with DCA increased exosome secretion (Figures R24A). 
To confirm the involvement of OXPHOS in exosome secretion, we promoted mitochondrial 
oxidative phosphorylation through fatty acid ß-oxidation by supplying fatty acids to wild-type 
and Tfam-/- T cells. In these conditions, activated wild-type CD4+ T cells increased oxidative 
respiration and reduced glycolysis, thus relying on fatty acid ß-oxidation and mitochondrial 
oxidative phosphorylation for energy production. In contrast,  Tfam-/- T cells fed with fatty acids 
showed severely reduced OCR supporting impaired fatty acid ß-oxidation (Figure R17). 
Treatment of cells with fatty acids, increased exosome secretion in wild-type cells but not in Tfam-
/- T cells (Figures R24B), which indicated that fatty acid ß-oxidation enhance exosome secretion 
in OXPHOS-competent cells but not in respiration-impaired Tfam-/- T cells. Altogether, these data 
suggest that mitochondrial OXPHOS is essential for exosome secretion.  
The main source of cellular reactive oxygen species (ROS) is mitochondria. We then explored 
whether mitochondrial ROS (mROS) regulate exosome secretion. T cells treated with N-
acetylcysteine (NAC), a ROS scavenger, showed reduced exosome secretion (Figure R24C), 
whereas induction of mROS by the complex I inhibitor rotenone resulted in robust mROS 
production and increased exosome secretion (Figure R24C). These results suggest that 
mitochondrial respiration regulates exosome secretion in a ROS-dependent manner. 
                  
 
 
4.10 Mitochondrial dysfunction promotes lysosomal disorder and sphingolipidosis  
Besides the defects in late endosomal maturation and exosome secretion, lysosomes, identified 
by staining for LAMP1 and Lysotracker, appeared to be more abundant in Tfam-deficient cells 
than in wild-types (Figure R25A-C), indicating expansion of the late endosome-lysosome 
compartment in cells that lack Tfam. Lysosomal biogenesis is regulated by TFEB, a master 
Figure R24. Mitochondrial OXPHOS regulates exosome secretion through ROS signaling. (A) Western blot 
analysis of exosome derived from control or DCA-treated T cells. (B) Protein immunoblot of the exosomal proteins 
CD63 and CD81, in the exosome fraction of shControl and shTfam cells supplemented with Albumax or Oleic acid for 
16h. (C) Protein immunoblot of CD63 and CD81, detected in the exosome fraction obtained from J77 T cells treated 
with rotenone (1µM) or NAC (5 mM) for 16h.   
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regulator of the CLEAR (coordinated lysosomal expression and regulation) gene network 
(Sardiello et al., 2009). During lysosomal stress or starvation, cytosolic TFEB relocates to the 
nucleus and activates a transcriptional program aimed at increasing autophagy, lysosomal 
biogenesis and function (Settembre and Ballabio, 2011; Settembre et al., 2013a). TFEB is also 
responsible for the transcriptional activation of PGC1, which adjusts the content of 
mitochondrial and peroxisomal enzymes and the expression of components that increase lipid 
catabolic reactions (Settembre et al., 2013b). Immunofluorescence analysis revealed that TFEB 
is mostly translocated to the nucleus in Tfam-depleted cells (Figure R25D). Nuclear localization 
of TFEB was confirmed by cell fractionation assays (Figure R25E), and correlated with 
upregulated expression of the TFEB target genes LAMP1, FABP3, CD36, Acacb, Cyp4a10 and 
PGC1 (Figure R25F), which are involved in lipid uptake, lipid catabolism and mitochondrial 
function. These results suggest that the enlarged lysosomal compartment observed in respiration-
impaired Tfam-/- cells is associated with TFEB activation.  
 
Figure R25. Tfam controls lysosomal biogenesis through TFEB. (A) Lysosomes content in T lymphocytes. (B) IF  
analysis of LAMP1 in T lymphocytes and (C) the oligodendroglia cell line (Oli-Neu). (D) Confocal subcellular localization 
of TFEB (green) and LAMP1 (red) in Oli-Neu cells. Graph, quantification of nuclear TFEB m.f.i. (E) Western blot analysis 
of TFEB in subcellular fractions in J77 T cells. Graph, ratio of nuclear TFEB to histone 2A. Cytosol and nuclear fractions 
were blotted for TFEB, tubulin (cytoplasmic marker), and histone 2A (nuclear marker). (F) mRNA levels of TFEB and 
selected target genes. Data are means ± SEM; *p<0.05, **p<0.01 and ***p<0.0001 (Student’s t-test).  
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To further examine the impact of Tfam deficiency on lysosome function, we measured the 
levels of calcium in lysosomes after inducing its release with bafilomycin-A1 (Lloyd-Evans et 
al., 2008), a selective inhibitor of the vacuolar-type H+ ATPase. Lysosomal calcium mobilization 
was weaker in Tfam-deficient cells (Figure R26A), whereas the subsequent addition of 
ionomycin, which releases calcium from remaining stores, triggered comparable release in wild-
type and Tfam-/- T cells. Measurement with a specific lysosomal pH-sensitive probe indicated 
reduced pH in lysosomes from respiration-deficient Tfam-/- cells (not shown). The activity of the 
lysosomal endopeptidase cathepsin B and was significantly reduced in Tfam-/- T cells (Figure 
R26B), whereas acid phosphatase activity showed no difference (not shown). 
 
 
 
 
Sphingomyelins and other lipids such as cholesterol, glycosphingolipids and sphingosine 
accumulate abnormally as a result of the impaired lysosomal degradation in metabolic diseases 
known as lysosomal storage disorders (LSDs) (Schulze and Sandhoff, 2011). Lipidomic analysis 
showed that CD4+ Tfam-/- T cells have an altered lipid profile compared with wild-type cells, 
affecting 90 out of 218 lipids analyzed and characterized by elevated levels of several lipid 
species. Consistent with the reduced lysosomal degradation capacity, respiration-impaired Tfam-
/- cells showed a significant accumulation of sphingomyelins and triacylglycerides (TAGs) 
(Figure R27). Supporting lysosomal dysfunction and sphingomyelin accumulation in respiration-
impaired cells, Tfam-/- T cells showed significantly reduced acid sphingomyelinase (ASM) 
activity (Figure R26C). 
Figure R26. Tfam controls lysosomal 
function. (A) Lysosomal calcium in T 
lymphoblasts loaded with the Indo-1, treated 
with bafilomycin-A1 and detected by flow 
cytometry. Left, Indo-1 340/380 nm ratio upon 
bafilomycin-A1 treatment and right, 
quantification of Indo-1 increase in bafilomycin-
A1- or ionomycin-treated cells relative to the 
basal level. (B) Cathepsin B activity measured by 
flow cytometry (MagicRed). Histogram and bar 
chart shows the quantification of mfi. (C) ASM 
activity in T lymphocytes. Data (B,C) are means 
± SEM of at least four independent experiments; 
*p<0.05 (Student’s t-test). 
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Figure R27. Abnormal sphingolipid accumulation in respiration-deficient cells. The heatmap represents 
cell lipidomic signatures of wt and Tfam-/-cells obtained from three mice per genotype, and shows the log2(fold 
change) and p-values for the detected metabolites. Log-transformed ion abundance ratios are depicted as shown 
in the scale. More intense colors indicate larger drops (green) or elevations (red) of the metabolite levels in 
Tfam-/- samples. Gray lines indicate significant fold changes of individual metabolites, with color intensity used 
to indicate statistical significance (p<0.05, p<0.01 or p<0.001) in Student’s t-test analysis. The metabolites 
present in the heatmap are ordered according to their carbon number and the degree of unsaturation of their 
acyl chains. Right panels show volcano plots [log10(p-value) vs. log2(fold change)] for the comparison of 
Tfam-/-and wild-type T cells for the indicated metabolites. DAG, diacylglycerides;  TAG, triacylglycerides; 
ChoE, cholesteryl esters; PE, phosphatidylethanolamines; PC, phosphatidylcholines; PI; phosphatidylinositols; 
Cer, ceramides; SM, sphingomyelins; CMH, monohexosylceramides.  
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Defects in lipid trafficking and autophagosome-lysosome fusion are commonly observed in 
sphingolipidoses. The reduced lysosomal calcium and abnormal sphingomyelin accumulation 
detected in respiration-impaired cells prompted us to investigate the ability of lysosomes to fuse 
with autophagosomes. In cells transfected with the autophagosome marker LC3GFP-RFP, GFP 
fluorescence is decreased when autophagosomes fuse with lysosomes because it is more sensitive 
to pH than the RFP signal, which is maintained in acidic compartments. In these experimental 
settings, control cells showed increased RFP puncta upon induction of autophagy by rapamycin 
treatment (Figure R29). In contrast, Tfam-deficient cells showed a significant reduction in the 
number of RFP-positive puncta, indicating impaired autophagosome-lysosome fusion in the 
absence of Tfam.  
 
 
Assessment of mitochondrial degradation by mitophagy upon acute membrane depolarization 
with CCCP revealed larger parkin-GFP aggregates in Tfam-deficient cells than in control cells 
(Figure R30A), indicating impaired parkin clearance and mitochondrial degradation. In 
accordance with impaired autophagic flux, Tfam–depleted cells showed increased levels of the 
lipidated form of LC3 (LC3-II) (Figure R30B). Additionally, flow cytometry, western blot and 
confocal analysis showed a significant accumulation of the autophagic substrate p62 in Tfam-
deficient cells (Figure R31). Blocking protein synthesis with cycloheximide revealed slower p62 
turnover in respiration-impaired cells than in wild-types, confirming that the accumulation of p62 
was caused by impaired lysosomal degradation and not by increased mRNA transcription (Figure 
R31).  
Cells that lack Tfam exhibit lysosomal defects similar to those seen in LSDs: abnormal lipid 
trafficking, altered calcium mobilization and defective autophagosome-lysosome fusion. Overall, 
these results reveal a novel link between a primary mitochondrial dysfunction and the acquisition 
of a lysosomal storage disorder. 
Figure 28. Autophagosome-lysosome 
fusion defects in Tfam deficient cells. Oli-
Neu were transfected with GFP-RFP-LC3 
and treated or not with rapamycin. 
Representative confocal images are shown 
in the left panel. The graph shows percentage 
of the GFP/RFP puncta (yellow vesicles) and 
the percentage of RFP puncta (red vesicles) 
from at least 100 vesicles in two independent 
experiments.  Nuclei were stained with 
HOESCHT58 (blue). 
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To dissect how mitochondria regulate lysosomal function, we investigated whether cells 
containing point mutations in mtDNA genes for specific mitochondrial respiratory complexes 
undergo the same lysosomal calcium defects. Mouse fibroblasts that carry a high load (98%) of a 
Figure 30. Impaired autophagic degradation in Tfam-deficient cells. Analysis of p62 by western blot, 
flow cytometry and confocal immunofluorescence in T lymphoblasts. Bar chart, densitometry analysis of 
p62 by western blot (n = 4). **p<0.01 (Student’s t-test). Western blot analysis of p62 protein turnover in 
cells treated with cycloheximide for the indicated times. 
Figure 29. Impaired mitophagy in Tfam-deficient cells. (A) Immunofluorescence microscopy in OliNeu 
cells transfected with Parkin-GFP and left untreated or cccp-treated during 4h. Representative confocal 
images are shown on left panel. Graph, quantification from the area of at least 100 vesicles in two 
independent experiments. Images show the subcellular localization of Parkin-GFP (green). Nuclei were 
stained with HOESCHT58 (blue). (B) Western blot analysis of LC3 in the indicated conditions.  
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null mutation in the mt-ND6 gene (complex I subunit) showed impaired lysosomal calcium 
mobilization, upregulation of TFEB target genes, and reduced ASM activity (Figure R32A). 
Notably, impaired lysosomal calcium mobilization was also detected in fibroblasts from two 
human patients, one carrying a high load (88%) of a point mutation in the mt-tRNAAsn gene 
(m.5658T>C), and another carrying a 50% load of a point mutation in the complex I subunit mt-
ND5 gene (m.13513G>A) (Figure R32B). These results indicate that lysosomal calcium levels 
are decreased not only by the severe OXPHOS-deficiency associated with Tfam-depletion, but 
also by point mutations in mtDNA associated with complex I dysfunction, both in mice and in 
human patient samples. 
              
 
 
 
Figure R31. Punctual mutations in mtDNA impair lysosomal function in human and mice. (A) Left, 
ratio of Indo-1 signal upon bafilomycin-A1 treatment relative to the basal level. Center, mRNA levels of 
TFEB and selected target genes. Right, acid sphingomyelinase (ASM) activity. (B) Lysosomal calcium in 
human fibroblasts. Right, Indo-1 340/380 nm ratio in cells upon bafilomycin-A1 treatment. Data are means 
± SEM of three independent experiments; *p<0.05 and **p<0.01 (Student’s t-test).   
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4.11 Increasing intracellular NAD+ content boosts lysosomal function and dampens 
Th1 responses in respiratory-deficient cells 
 
We then investigate whether lysosomal dysfunction caused by mitochondrial respiration 
deficiency is involved in the increased inflammatory responses observed in Tfam-deficient cells. 
Naive wild-type CD4+ T cells activated in the presence of the lysosomal inhibitor leupeptin or 
sphingomyelin (SM) showed increased levels of IFN-γ mRNA (Figure R33), suggesting that the 
lysosomal dysfunction caused by mitochondrial respiration-deficiency might contribute to the 
increased pro-inflammatory profile of Tfam-/- CD4+ T cells.  
 
 
To ascertain the involvement of lysosome function in the regulation of T cell responses, we 
studied T cell activation and differentiation in mice lacking the acid sphingomyelinase, which 
mimics the LSD Niemann Pick disease Type A (NPA) and, similarly to Tfam-/- , shows SM 
accumulation, lysosomal disorder and autophagy impairment (Gabande-Rodriguez et al., 2014). 
Naive CD4+ T cells from ASM-/- mice activated in non-skewing conditions with anti-CD3 and 
anti-CD28 antibodies showed a higher frequency of IFN--producing cells than wild-type CD4+ 
T cells (Figure R34A). In addition, naive CD4+T cells from wild-type and ASM-/- mice were 
differentiated in vitro toward Th1 subsets. Similarly to respiratory-deficient Tfam-/- cells, ASM-/- 
cells showed higher frequency of IFN--producing cells, and higher levels of IFN-γ secretion 
(Figure R34A and R34B). Collectively, these results showed that lysosome dysfunction caused 
by ASM deficiency deregulates efficient T cell differentiation toward pro-inflammatory Th1 T 
cell subset.  
Figure R32. Lysosomal dysfunction increases inflammatory responses. mRNA levels of IFN- in 
CD4+ T cells activated for 6 days with anti-CD3/CD28 in the presence of leupeptin (1 µM) or 
sphingomyelin (25 µM). Results are expressed relative to untreated cells, and data are means ± SEM of 
three independent experiments. 
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Increasing intracellular levels of NAD+ has been proposed to be a therapeutical strategy to 
restore mitochondrial function in respiratory-chain deficiencies (Cerutti et al., 2014; Gomes et al., 
2013; Karamanlidis et al., 2013; Mouchiroud et al., 2013). To assess whether modulation of the 
cellular NAD+/NADH ratio may be involved in the regulation of lysosomal function, we treated 
Tfam-deficient T cells with the nicotinamide precursor NAM to reestablish NAD+/NADH 
balance, and assessed parameters of lysosome function. Addition of NAM increased ASM 
activity, reduced p62 accumulation, and downregulates TFEB target genes in Tfam-deficient cells 
(Figure R35A-C), suggesting that modulation of mitochondrial NAD+/NADH levels impacts 
lysosome function. Finally, to determine whether restoring lysosomal function would limit the 
increased pro-inflammatory profile in respiration-impaired Tfam-/- T cells, naive CD4+ T cells 
were activated in the presence of NAM for 72h and their cytokine profile assessed. NAM 
treatment reduced the frequency of IFN--producing Tfam-/- T cells (not shown). Additionally, 
under Th1 polarization conditions, naive Tfam-/- CD4+ T cells cultured in the presence of NAM 
showed a reduced percentage of IFN--producing cells (Figure R35D), indicating that improved 
lysosomal function reduces the exacerbated inflammatory response of mitochondrial respiration-
deficient cells.  
Figure R33. Lysosomal dysfunction increases inflammatory responses. (A) CD4+ T lymphocytes 
from acid sphingomyelinase-deficient (ASM-/-) and wt mice, activated with anti-CD3/CD28 or under 
Th1 differentiation. Flow cytometry analysis and quantification of the frequency of CD4+ T cells 
producing IFN- (B) IFN- levels in the supernatant were measured by ELISA (left panel). Data are 
means ± SEM (n=3); *p<0.05 (Student’s t-test). 
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Figure R34. Increasing NAD+ levels improves lysosome function and reduces inflammatory responses 
in Tfam-deficient cells. (A) ASM activity, (B) p62 levels and (C) mRNA levels of TFEB target genes in T-
lymphoblasts treated with the nicotinamide precursor NAM (10mM) for 2 days. (D) Flow cytometry analysis 
and quantification of IFN--producing cells in CD4+ T cells cultured towards Th1 conditions in the presence 
of absence of NAM. Data are means ± SEM; *p<0.05 and **p<0.01 (Student’s t-test).  
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5. Discussion  
 
Here we present evidence suggesting a critical role for mitochondria in the regulation of 
adaptive immune responses. Our results underscore a fundamental role of mitochondria in almost 
every step of T cell function, starting with the control of IS organization and early TCR signaling 
to T cell differentiation, cytokine production and regulation of the outcome of immune responses. 
By regulating IS organization and the balance between OXPHOS and glycolysis, mitochondria 
provide a metabolic context appropriate for efficient regulation of inflammatory responses. In 
addition, our results on the functional regulation between mitochondria and the endolysosomal 
compartment link for the first time these organelles and provide a novel role for mitochondria in 
the regulation of MVB maturation, exosome biogenesis and secretion. Finally, we present 
evidence indicating a major role of mitochondria in the regulation of lysosome biogenesis and 
function, which associate mitochondrial deficiencies and lysosomal storage disorders.  
The mitochondrial network: how to fuel the IS. 
Mitochondria are actively relocalized to cellular places with high demand of ATP or 
where the buffering of intracellular Ca2+ flux is needed. The best example of the importance of 
mitochondrial positioning occurs in highly polarized cells such as neuronal cells, in which 
mitochondria preferentially relocate into synaptic structures to fuel neurotransmitter release and 
regulation of calcium signaling (MacAskill and Kittler, 2010). In the immune system, 
lymphocytes are not inherently polarized, do not show strong front-rear polarity in the absence of 
stimulation and organelles are usually evenly distributed within the cytosol. However, following 
migration in response to soluble stimuli such as chemokines and stimulation through cell-cell 
contact with antigen-presenting cells (APC), T cells adopt front-rear polarity. Contact with the 
APC and subsequent TCR-induced signaling triggers rapid cytoplasmic and membrane 
remodeling within the T cell that recruits organelles such as mitochondria, the secretory apparatus, 
and signaling machinery to the contact site to efficiently orchestrate the events of the immune 
response (Martin-Cofreces et al., 2014).  
The findings presented here describe how mitochondria preferentially localize into the 
vicinity of the IS upon TCR activation where these organelles exert an important role in T cell 
activation by regulating calcium signaling and the orchestration of IS formation and stability 
(Baixauli et al., 2011). The movement and localization of mitochondria towards the IS depends 
on the fusion and fission dynamics of mitochondria, although other factors have been described, 
such as integrin adhesion, cell polarization or transport along cytoskeleton by kinesin and dynein 
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motor proteins (Baixauli et al., 2011; Contento et al., 2010; Morlino et al., 2014; Quintana et al., 
2007).  
Increased ATP levels and mitochondrial ROS produced at the IS are needed for energy-
consuming signaling at the IS (Ilani et al., 2009). Our results indicate that mitochondria play a 
particularly important role at the IS by supporting sustained calcium influx that is required to 
support synaptic signaling and T cell effector functions (Kummerow et al., 2009). In addition, we 
demonstrate that energy supply is also needed for the ATP-dependent acto-myosin centripetal 
flux of TCR to the cSMAC (Baixauli et al., 2011), which is important for the termination of TCR 
signals by internalization and degradation of the CD3/TCR complexes. The findings presented 
here provide evidence that the mitochondrial fission protein Drp1 modulates T cell activation at 
the IS. Mitochondrial fission factor Drp1 regulates mitochondria localization towards nascent IS 
and there regulates energy supply and impacts IS architecture and TCR signal strength. 
Mitochondrial recruitment to the IS in T cells is impaired by blockade of Drp1 action, whether by 
siRNA silencing, treatment with the Drp1 inhibitor mdivi-1 or overexpression of a 
phosphomimetic S637D Drp1 mutant unable to bind to the OMM (Baixauli et al., 2011). 
Impairing Drp1 decreases centripetal flux of TCR to the cSMAC and increases persistent TCR 
activity within microclusters, proximal TCR signaling and IL-2 production. Thus, Drp1-
dependent mitochondria redistribution is required for both the proper organization of the IS and 
the regulation of the intracellular signaling pathways generated through the TCR. Collectively, 
our results support a role for mitochondria not only in the regulation of the strength of T cell 
activation but also in the termination of IS signaling. 
The finding that mitochondrial fission factors are involved in IS formation and T cell 
function further emphasizes the commonalities between the immune and neural systems. Proper 
distribution of mitochondria at dendritic spines and synapses is essential for neural function (Li 
et al., 2004) and neural specific deletion of Drp-1 decreases the number of neurites and promotes 
defective synapse formation (Ishihara et al., 2009). The actin-rich area of the pSMAC is highly 
homologous with the actin-rich areas at neuronal postsynaptic termini. These actin-rich, 
membrane receptor-driven structures serve as scaffolds for selective and profuse secretion, and 
our finding that mitochondria dock at the actin-rich pSMAC area of the IS suggests that similar 
mechanisms operate in T cells. Whereas actin is involved in mitochondrial docking at neuronal 
synapses (Hollenbeck, 2005; Macaskill et al., 2009), mitochondrial trafficking is dependent on 
microtubules and members of the microtubule-associated kinesin and dynein motor-protein 
families. Mutations in dynein heavy chain or p150GLUED block axonal mitochondrial 
trafficking, affecting both anterograde and retrograde transport (Pilling et al., 2006). 
Dynein/dynactin motor complexes are important for T cell activation, mediating MTOC 
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translocation and the formation of the CD3/TCR central cluster at the IS (Martin-Cofreces et al., 
2008). In this regard, we also observed a defect in mitochondria re-localization at the IS when 
dynein/dynactin motor activity is inhibited. How Drp1-mediated mitochondrial fission facilitates 
transport remains unclear. It is feasible that binding to mitochondria exposes the dynein-binding 
site on Drp1 or that dynein more efficiently traffics fragmented mitochondria than an extensively 
fused mitochondrial meshwork. This would imply that dynein-dependent trafficking coordinates 
MTOC movement with mitochondrial activity for the local delivery of biological mediators at the 
IS, similar to the relationship observed between the MTOC and the T cell secretory machinery 
(Huse et al., 2006; Kupfer et al., 1986). MTOC translocation is unaffected by Drp1 silencing, 
providing further evidence that dynein/dynactin transports not only the MTOC but also 
mitochondria towards the IS through coordinated action with Drp1. 
Mitochondrial trafficking and positioning have been demonstrated to be important during 
the contact between viruses and lymphocytes in the virological synapse (VS). The VS shares 
many similarities with the IS, including synaptic enrichment of adhesion proteins, formation of a 
receptor-bearing complex at the contact zone, cytoskeletal rearrangements, and polarized budding 
of virus that is reminiscent of polarized secretion from T cells at the IS. Electron microscopy 
tomographic reconstructions of the HIV-1 T cell VS have revealed the cytoplasmic polarization 
and clustering of organelles such as mitochondria and the MTOC proximal to the plasma 
membrane at the contact zone spatially associated with HIV-1 budding (Groppelli et al., 2015; 
Jolly et al., 2011). Mitochondria are actively recruited to the VS and inhibiting mitochondrial 
trafficking and positioning by treating cells with the mitochondrial fission inhibitor mdivi-1 
reduces T cell motility and cell-cell spread of the viruses (Groppelli et al., 2015). 
Mitochondrial positioning and immune synapse architecture 
Here, we demonstrate a critical role of mitochondrial positioning and mitochondrial 
shaping proteins in the efficient formation and function of the IS between T lymphocytes and 
APCs. TCR activation is initiated in the early-assembled peripheral microclusters of TCR/CD3 
complexes, and downmodulated in the central supramolecular activation complex (cSMAC), 
where activated TCR/CD3 signaling complexes are switched off after ubiquitination, 
internalization and degradation by CD2AP and members of the Cbl ubiquitin ligase and ESCRT 
families (Malissen, 2003; Vardhana et al., 2010; Varma et al., 2006). Therefore, trafficking and 
internalization of TCR/CD3 complexes and stimulatory molecules at the IS is critical for efficient 
fine-tuning of TCR signaling, as it is for the switching-off of the signal.  
The cSMAC is thus considered a focal point where endocytosis reduces TCR/CD3 
complexes and the number of CD28 co-stimulatory molecules engaged by CD80 or CD86 
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receptors at the APC (Qureshi et al., 2011), and exocytosis allows the unidirectional transfer of 
cytokines and microRNA-loaded exosomes from T cells to APCs (Mittelbrunn et al., 2011). In 
addition, a phagocytosis-dependent process has been depicted at a similar area of the IS, which 
would be clathrin-independent and import pMHC complexes bound to the TCR/CD3 
signalosomes (Martinez-Martin et al., 2011). Our finding showing that reduced cSMAC assembly 
of CD3 in Drp1 silenced T cells is associated with increased activation of TCR proximal elements 
suggests that, by controlling cSMAC organization, Drp1 modulates T cell activation and function.  
Our data underscore the importance of mitochondrial positioning for fueling molecular 
motors involved in IS formation, such as myosins. Myosin IIA is concentrated at the IS, from 
where it is suggested to control actin flux at the actomyosin contractile ring formed beneath the 
pSMAC (Ilani et al., 2009). The contractility of this ring is regulated by phosphorylation of 
myosin regulatory light chain (MLC) and is important for directing TCR/CD3 microclusters to 
the cSMAC. Silencing of myosin IIA prevents the formation of the cSMAC and the amplification 
of TCR signals (Ilani et al., 2009). Accordingly, our data show that Drp1 silencing reduces MLC 
phosphorylation at Ser19, elevates the number of CD3 microclusters, and disrupts TCR/CD3 
complex organization at the cSMAC. A similar effect on MLC phosphorylation has been 
described for Drp1 mutants during the mobilization of pool vesicles at Drosophila neuromuscular 
junctions (Verstreken et al., 2005). Our findings provide a plausible explanation of how 
mitochondrial de-localization from the IS might disturb cSMAC formation and subsequent 
signaling. By reducing actomyosin fueling at the IS, mitochondrial de-localization in Drp1-
interfered T cells slows centripetal flux of TCR/CD3 microclusters, thus enhancing signaling by 
maintaining TCR/CD3 complexes away from cSMAC-localized degradation pathways. 
Interestingly, other studies propose a similar role for Drp1 in the regulation of neuronal synapses 
by controlling mitochondrial positioning and function. In this respect, the pro-apoptotic Bcl-2 
family member Bcl-xL regulates Drp1 to alter mitochondrial function in a manner that stimulates 
synapse formation (Li et al., 2008). Alternatively to altering mitochondrial function, Bcl-xL is 
able to directly regulate endocytic vesicle retrieval in hippocampal neurons mediating protein–
protein interaction of Drp1 with components of the clathrin complex (Li et al., 2013). Thus, these 
data point that Drp1 could regulate TCR signaling and IS architecture directly regulating 
TCR/CD3 endocytic events at the IS through its binding to clathrin. 
Mitochondrial function and TCR signaling 
Our results showing that Drp1 silencing increases mitochondrial depolarization in 
stimulated and non-stimulated T cells argue for a direct role of Drp1 in controlling mitochondrial 
function during T cell activation. Enhanced mitochondrial depolarization prevents both the 
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Proposed model for DRP1, mitochondrial localization and IS formation. (A) After IS formation with an 
antigen‐presenting cell, mitochondria are transported towards the IS, where they provide proper energy 
supply for synaptic signalling including centripetal flux of TCR microclusters towards the cSMAC by 
myosin motors. (B) Inhibition of DRP1 induces unopposed fusion of mitochondria and they cannot be 
transported as well to the pSMAC. Baixauli et al, 2011 highlighted in (Junker and Hoth, 2011). 
 
clustering of the TCR/CD3 at the cSMAC and the cessation of TCR-dependent signaling, 
resulting in persistent T cell activation, intracellular Ca2+ flux and diminished ATP synthesis. 
Mitochondria located at sites of T cell stimulation control local Ca2+ influx (Schwindling et al., 
2010), and our results therefore support a role for Drp1 in the regulation of mitochondrial 
positioning required for efficient Ca2+ signaling at the IS. The IS is the main entry point for Ca2+ 
upon TCR stimulation (Schwindling et al., 2010), which suggests that Drp1 impedes intra-
mitochondrial diffusion of Ca2+ during TCR signaling by maintaining the compartmentalization 
of the mitochondrial network at the IS through fission events. In this regard, our results support 
the notion that T cells fine tune TCR responses through Drp1-mediated regulation of 
mitochondrial positioning and activity and underlie the importance of mitochondrial shape for the 
ability of the cell to respond to different cues. Furthermore, mitochondria positioning at the IS is 
essential for the management of intracellular Ca2+ levels, and Drp1-dependent fragmentation of 
the mitochondrial network may serve to protect T cells from amplified calcium signaling triggered 
by activation.  
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Further work is needed to address the relation between mitochondrial dynamics and 
transport machineries, to determine how mitochondria are anchored to the IS, and to identify the 
signals that relocate mitochondria to sites of high energy demand and Ca2+ buffering, such as 
extracellular glucose uptake, which has been demonstrated to control mitochondrial motility by 
regulating the activity of Miro-Milto complex (Pekkurnaz et al., 2014). Remarkably, exploring 
whether mitochondrial shaping proteins control the unequal partitioning of mitochondria during 
cell division depending on the different metabolic requirements of the specific T cell subsets, will 
also be of great interest. 
Tfam-deficient mice as a model to study mitochondrial function 
Although the different metabolic profiles of T cell subsets are well documented, it 
remains unclear why these cells must adopt these very different metabolic phenotypes for their 
differentiation and whether these metabolic changes are instructive versus responsive. Notably, it 
is being increasingly appreciated that metabolic pathways provide more than just ATP and 
biosynthetic intermediates, and importantly provide signaling intermediates that are essential for 
cellular function and also influence T cell fate. 
Besides energy supply, mitochondria perform many other cellular functions that can 
participate during the orchestration of an adaptive immune response. The use of specific 
mitochondrial inhibitors and the few available genetic models of mitochondrial deficiency in T 
cells have underscored important and unanticipated functions of mitochondrial metabolism in the 
regulation of T cell activation, differentiation and fate (Weinberg et al., 2015). To understand how 
mitochondria influence T cell differentiation and ultimately affect immune disease progression, 
we have generated a mouse model of mitochondrial dysfunction by deleting Tfam in the T cell 
compartment using the CD4Cre LoxP system. Consistent with its role in the maintenance of 
mtDNA transcription and replication, deletion of Tfam in T lymphocytes promotes a reduction in 
the levels of mtDNA and the transcripts encoding the mitochondrial subunits of the ETC. 
Consequently, Tfam deletion reduces mitochondrial supercomplex assembly, electron transport 
between respiratory complexes and decreases mitochondrial ATP production. Besides these 
profound mitochondrial alterations, Tfam-deficiency triggers a general mitochondrial dysfunction 
without altering the general energetic status of the cell, as evidenced by the similar levels of total 
ATP and the absence of AMPK activation. In addition, metabolic flux experiments demonstrate 
that Tfam-/- cells maintain their energy status by promoting a “metabolic switch” characterized by 
increased anaerobic glycolysis and reduced OXPHOS. Importantly, deletion of Tfam in 
lymphocytes does not affect T cell development since similar numbers and proportions of CD4 T 
cells are found in the thymus and secondary lymph nodes from wild-type and Tfam-/- mice. 
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Proposed model for 
mitochondria in the 
regulation of adaptive 
immune responses. Critical 
role for mitochondria in the 
regulation of T cell 
inflammatory responses by 
controlling lysosome function. 
Abnormal endolysosomal 
function and sphingomyelin 
accumulation in respiration-
impaired cells link 
mitochondrial dysfunction to 
lysosomal storage disorders 
and exacerbated inflammatory 
responses (Baixauli et al., 
2015). 
 
 
Altogether, these data support the use of Tfam-/- as a suitable genetic mice model to study 
mitochondrial function in T cell responses either in vitro or in vivo, and investigate novel 
functions of mitochondria during adaptive immune responses (Baixauli et al., 2015). Using this 
model, we reveal a critical role of mitochondria coordinating cellular metabolism and the 
biogenesis and function of the endolysosomal compartment during T cell activation and 
differentiation.  
 
 
Mitochondrial OXPHOS regulates T cell activation, proliferation and differentiation 
Activation of T cells is intimately linked to the engagement of specific metabolic pathways. 
This metabolic reprogramming is associated with a global change in the transcriptome linked to 
c-Myc and Hif-1 activation. Hif-1maintains T cell glycolytic activities after entry into the cell 
cycle (Wang et al., 2011), whereas Myc drives the transcriptional program that coordinates 
glucose metabolic enzymes, glutamine catabolism (Gao et al., 2009), and mitochondrial 
biogenesis (Li et al., 2005). Glutamine provides a major source of energy and nitrogen for 
biosynthesis and a carbon substrate for anabolic processes in proliferating cells. Glutamine 
catabolism is tightly coupled to several biosynthetic pathways, but also generates the anaplerotic 
substrate α-ketoglutarate (α-KG), that is metabolized through the TCA cycle to generate citrate 
or pyruvate. Therefore, metabolism in proliferating cells, especially of glutamine, relies on 
continued mitochondrial function. In this regard, Myc also acts as a strong promoter of 
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mitochondrial biogenesis and induces the expression of many nuclear-encoded mitochondrial 
genes, among them, Tfam (Gomes et al., 2013). Our results show the concomitant increases in 
Tfam mRNA expression and mtDNA content during T cell activation, and suggest that metabolic 
reprogramming of T cells critically depends on mitochondrial function achieved in part through 
increased Tfam expression, most likely through upregulation of Myc transcriptional activity. 
Our data support the role of mitochondria as central hubs integrating cellular metabolism, and 
emphasize the requirement of a tightly regulated mitochondrial function to fine tune the process 
of T cell activation. Mitochondrial respiration-deficient cells do not show altered T cell activation, 
but showed decreased proliferation and elevated IFN-γ secretion, concomitantly with an increased 
anaerobic glycolysis and reduced OXPHOS function. A recent study has demonstrated the 
mechanistic link between metabolic pathways and acquisition of T cell effector functions (Chang 
et al., 2013). The glycolysis enzyme GAPDH can repress IFN- mRNA expression by binding to 
its 3’-UTR. Upon T cell activation, engagement of aerobic glycolysis releases GAPDH from the 
3’-UTR and allows IFN-γ mRNA expression (Chang et al., 2013). Based on these findings, we 
suggest that the metabolic reprogramming towards glycolysis in Tfam-/- T cells might contribute 
to their increased IFN- production. 
Distinct metabolic pathways support the differentiation of CD4 T helper (Th) cells into 
their separate lineages. Our results reveal a role for mitochondrial respiration in the regulation of 
T cell differentiation, and indicate that mitochondrial dysfunction is associated with a 
deregulation of T cell differentiation toward pro-inflammatory Th1 cell subsets. Mitochondrial 
respiration-deficiency, which promotes a metabolic switch toward increased glycolysis and 
impaired fatty acid β-oxidation, favors the differentiation of pro-inflammatory Th1 subsets and 
dampens Th2 and Th17 differentiation. Interestingly, in other cells of the immune system, 
impaired mitochondrial respiration has been also associated with increased inflammatory 
responses. In macrophages, glycolysis is essential for pro-inflammatory M1 macrophage 
activation, whereas IL-4 induces lysosomal lipolysis and fatty acid oxidation essential for M2 
activation (Huang et al., 2014). Interestingly, succinate accumulation promoted by impaired 
mitochondrial function, decreases prolyl hydroxylase activity, stabilizes Hif-1α and enhances IL-
1β production (Tannahill et al., 2013), a mechanism likely contributing to the increased pro-
inflammatory profile of Tfam-deficient T cells. 
Glycolysis is important in driving Th17 differentiation through Hif-1(Pearce et al., 
2013). Hif-1α stabilization mediates Foxp3 proteosomal degradation and induction of Th17 cells 
(Dang et al., 2011; Shi et al., 2011). Additionally, a recent report describes the greater reliance on 
glutamine metabolism of Th17 cells (Gerriets et al., 2015). Tfam-/- T cells show impaired Th17 
differentiation and reduced number of IL-17-producing cells and IL-17 secretion. Besides the 
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prominent Hif-1α stabilization and increased glycolytic activity in respiration-deficient cells, 
defective glutaminolysis, which requires an intact ETC for its function, could explain the impaired 
Th17 differentiation observed in mitochondrial respiration-deficient cells. Nevertheless, our 
results show that mitochondrial respiration-deficiency favors the appearance of Th17 cells which 
co-express RORγt and T-bet, and produce high levels of IFN-γ but reduced amounts of IL-17 and 
IL-10, and which have been proposed to be pathogenic Th17 cells involved in autoimmune 
diseases in mice (Peters et al., 2011). With respect to Treg cells, we found similar numbers of 
Foxp3-expressing cells in wild-type and Tfam-/- cells but reduced amounts of the anti-
inflammatory cytokine IL-10 in respiration-deficient cells. These results, together with the 
exacerbated in vivo inflammatory responses of Tfam-/- mice, support the critical role of 
mitochondrial function in Th17/Treg differentiation and function. Overall, our results suggest that 
cues derived from mitochondria besides regulation of cellular bioenergetics, can modulate the 
appearance of pathogenic Th17 cells and regulate inflammatory responses. 
Mitochondria regulate the endolysosomal compartment during inflammatory responses  
Our findings reveal a critical role for mitochondria in the regulation of endolysosomal 
function and the differentiation of pro-inflammatory T cell subsets, and identify mechanisms by 
which mitochondrial dysfunction might contribute to human disease by affecting the 
endolysosomal compartment. We show that lack of Tfam switches metabolism from aerobic FAO 
to anaerobic glucose consumption. This altered mitochondrial metabolism is associated with 
abnormal accumulation of lipids, especially sphingomyelins (SM), impaired endolysosomal 
function, and increased differentiation of pro-inflammatory T cell subsets, which promotes T cell 
differentiation toward the pro-inflammatory Th1 subset and dampens Th2 and Th17 
differentiation. Our results support that loss of lysosomal homeostasis by a primary mitochondrial 
dysfunction triggers pro-inflammatory T cell responses. The lysosomal dysfunction and increased 
SM levels in respiration-deficient T cells appear to be associated with the acquisition of a pro-
inflammatory profile. We show that lysosomal dysfunction triggered by pharmacological 
inhibition or the use of acid sphingomyelinase deficient T cells (ASM-/-), a mice model of 
Niemann-Pick type A disease, show a similar pro-inflammatory cytokine profile than Tfam-
deficient T cells, indicating that lysosomal dysfunction is sufficient to exacerbate pro-
inflammatory responses in cells without altered mitochondrial respiration. Accordingly, immune 
deviation toward Th1 response and reduction of Th2 differentiation has been observed in a mouse 
model of Gaucher disease (Pandey et al., 2012) and the contribution of lysosomal homeostasis to 
the regulation of T cell function during adaptive immune responses has been recently 
demonstrated (Valdor et al., 2014).  
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It is well known how lysosomes regulate innate immune responses. Lysosomal  
destabilization regulates the release of highly pro-inflammatory cytokines interleukin-1β (IL-1β) 
and IL-18 by triggering inflammasome activation (Hornung et al., 2008). In addition, lysosomal 
degradation of TLR4 and TLR9 regulates pro-inflammatory cytokine production in macrophages 
(Wang et al., 2007; Yao et al., 2009). Furthermore, lysosomal biogenesis through TFEB plays a 
critical role in innate immunity and antiviral defense (Hasan et al., 2013). A recent publication 
shows how lysosomal function could regulate immune response by modulating cellular 
metabolism; by degrading key glycolytic enzymes, lysosome function regulates glycolysis and 
the production of effector cytokines, including IFN- and IL-1 (Lu et al., 2014). Concomitantly 
with the metabolic reprogramming, abnormal lipid accumulation, lysosome destabilization and 
impaired degradation capacity in Tfam-deficient T cells, might contribute to the exacerbated pro-
inflammatory response of mitochondrial respiration-deficient cells. 
Linking mitochondrial deficiencies to lysosome storage diseases 
Lipid metabolism and the maintenance of membrane homeostasis require an extensive 
exchange of lipids and metabolic intermediates between cellular organelles. Our study identifies 
Tfam as a key player in the regulation of lipid metabolism that impacts endolysosomal-autophagy 
pathway and the membrane reorganizations required for MVB maturation and exosome secretion. 
Sphingomyelins and other lipids such as cholesterol, glycosphingolipids and sphingosine, 
abnormally accumulate in a group of inherited diseases referred to as lysosomal storage disorders 
(LSDs) (Schulze and Sandhoff, 2011). For instance, sphingosine accumulation is an initiating 
factor in Niemann-Pick disease type C1 (NPC1), pathogenesis that causes altered lysosomal 
function, leading to the secondary storage of sphingolipids and cholesterol (Lloyd-Evans et al., 
2008). Cholesterol accumulation directly affects the fusion of lysosomes with endosomes and 
with autophagic vacuoles by affecting the assembly and recycling of SNAP and SNARE proteins 
(Fraldi et al., 2010). Niemman Pick type A (NPA) is a sphingolipidosis caused by loss of function 
mutations in the gene SMPD1 encoding for the acid sphingomyelinase (ASM), enzyme that 
catalyzes sphingomyelin conversion into ceramide in lysosomes. Cells from NPA patients 
accumulate sphingomyelin in their lysosomes and present impaired protein degradation and 
macroautophagy (Gabande-Rodriguez et al., 2014). The accumulation of sphingomyelins in 
respiratory-deficient cells supports the hypothesis that lipid metabolism imbalance resulting from 
mitochondrial dysfunction is associated with lysosomal storage disease.  
Previous studies have examined the role of Tfam in neurodegenerative diseases. Specific 
deletion of Tfam in neurons induces progressive parkinsonism in mice (Ekstrand et al., 2007), 
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and Tfam deletion in Schwann cells induces a neuropathy associated with axon degeneration and 
demyelination caused by the accumulation of acylcarnitines (Viader et al., 2013). Our findings on 
the role of mitochondrial respiration as a regulator of endolysosomal function may provide novel 
insights into the mechanisms by which mitochondria are involved in neurodegenerative diseases 
by regulating lysosomal degradative capacities. The connection between lysosomes and 
mitochondrial function is illustrated by Gaucher disease, in which a primary lysosomal defect 
causes accumulation of dysfunctional mitochondria and links lysosomal function to the 
preservation of mitochondrial integrity (Osellame et al., 2013). On the contrary, we provide herein 
the first evidence for a primary mitochondrial dysfunction leading to altered lysosomal function 
and sphingolipidosis. We also identify OXPHOS as a key regulator of lipid metabolism that 
influences membrane reorganization essential for endolysosomal and autophagy pathways. Our 
data indicate that either lowering the levels of mtDNA by Tfam deletion or punctual mtDNA 
mutations found in patients with OXPHOS deficiency impair lysosomal function. 
Autophagy and lysosomes regulate lipid metabolism through a regulatory network linked 
to the activation and nuclear translocation of the transcriptional factor TFEB (Settembre et al., 
2013a). A predominant nuclear localization of TFEB, however, has been detected in cells from 
LSD mouse models, suggesting that the TFEB pathway is activated after intralysosomal storage 
of non-degraded molecules as a cellular response to lysosomal stress (Sardiello et al., 2009). 
Tfam-deficient cells showed increased autophagy markers, enlarged lysosomal compartments but 
decreased lysosomal function and degradation capacity. The activation of TFEB in Tfam-
deficient cells, as a physiological cell response to compensate the lysosomal dysfunction, supports 
the role of mitochondria in controlling the lysosomal compartment.  
Lysosomal calcium level is impaired not only by Tfam deletion, which triggers a general 
lowering of the levels of mtDNA, but also in cells from patients with point mutations in 
mitochondrial respiratory complex I. Mitochondrial complex I is essential for maintenance of the 
NAD+/NADH ratio through NADH dehydrogenase activity, and an imbalanced NAD+/NADH 
ratio in cancer cells with mutations in mitochondrial complex I subunits is associated with 
impaired autophagy and p62 degradation (Santidrian et al., 2013). Inhibition of complex I activity 
with rotenone in a mouse model of Parkinson’s disease impairs autophagic flux and promotes p62 
and alpha-synuclein accumulation (Wu et al., 2015). Our data demonstrate that NAD precursors 
restore ASM activity and prevent p62 accumulation in Tfam-deficient cells, thus supporting a role 
of mitochondrial respiratory complex I and NAD+/NADH ratio in the regulation of lysosomal 
function. In accordance, addition of NAM downregulates TFEB target genes in Tfam-deficient 
cells. These data support the notion that lysosomes adapt their biogenesis and function to the 
metabolic state of the cell by sensing intracellular NAD+/NADH levels. Further research is 
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necessary to understand how NAD precursors reestablish ASM activity and lysosomal function, 
and whether it relies on transcriptional regulation by NAD-dependent deacetylases. 
Mitochondrial metabolism in MVB biogenesis and exosome secretion. 
Mitochondria are intimately connected to other organelles. Mitochondria establish 
physical contacts with the ER that are essential for the transport of calcium and phospholipids 
from the ER to the inner mitochondrial membrane (Osman et al., 2011), and are tethered by 
mitofusin 2 (Mfn2) (de Brito and Scorrano, 2008). Mfn2 also regulates the contact between 
mitochondria and melanosomes, the lysosome-related organelles of pigment cells, and these 
contacts are involved in melanosome biogenesis and maturation (Daniele et al., 2014). A contact 
site has also recently been identified between mitochondria and the lysosome-like yeast vacuole, 
and reported to act as an alternative route for phospholipid import into mitochondria when ER-
mitochondria contacts are impaired (Elbaz-Alon et al., 2014; Honscher et al., 2014). These 
observations suggest the intriguing possibility that the impact of mitochondrial dysfunction on 
the endolysosomal system might be mediated through physical contacts between these organelles. 
Further investigations will be necessary to elucidate whether mitochondria physically connect 
with components of the endolysosomal compartment and to decipher the molecular mediators that 
participate in these contacts.  
Recently, it has been described that mitochondria form mitochondrial derived vesicles 
(MDVs) as an early response to oxidative stress (Braschi et al., 2010; Neuspiel et al., 2008). These 
MDVs shuttle oxidized mitochondrial proteins to the lysosomes in order to preserve the integrity 
of the organelle in a quality control mechanisms that connects mitochondria with lysosomes via 
the formation of these vesicles. In response to mitochondrial oxidative stress, parkin induces, in 
a PINK1‐dependent manner, the formation of mitochondrial vesicles, which are enriched for 
specific mitochondrial proteins. Thus, lysosomal targeting of MDVs constitutes an additional, 
mitophagy‐independent quality control mechanism (Sugiura et al., 2014). It will be interesting to 
address whether MDVs support lysosome function or mediate the specific trafficking of lipids 
between mitochondria and lysosomes. In addition, it will be interesting to address the connection 
between MDVs and exosomes, and whether secretion of mitochondrial-derived content in 
exosomes can represent an additional quality control mechanism in circumstances in which cell 
degradation capacity is compromised.   
Our results highlight the critical role of mitochondrial metabolism in MVBs and exosomes 
biogenesis. Exosomes are secreted by almost all cells, and provide a vehicle for intercellular 
communication (Mittelbrunn and Sanchez-Madrid, 2012). Cells of the adaptive and innate 
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immune system release exosomes that influence the immune response in a non-cell autonomous 
manner (Mittelbrunn et al., 2011; Okoye et al., 2014; Robbins and Morelli, 2014). The molecular 
mechanisms that regulate exosome biogenesis depend on the endosomal sorting complex required 
for transport (ESCRT), lipids and tetraspanins (Villarroya-Beltri et al., 2014). For the first time, 
we demonstrate that mitochondria are critical organelles in MVB maturation and exosome 
secretion. Our data therefore suggest novel strategies to manipulate exosome production by 
modulating mitochondrial metabolism, and identify Tfam as a regulator of exosome biogenesis 
The regulation of lipid metabolism by mitochondria is critical in membrane organization during 
MVB maturation and exosome biogenesis since respiratory deficient Tfam-depleted cells showed 
empty MVBs and decreased exosome secretion. The sphingolipid ceramide segregates exosome-
associated microdomains to ILVs in a process dependent on neutral sphingomyelinases 
(Trajkovic et al., 2008). The phospholipid lysobisphosphatidic acid (LBPA) facilitates the inward 
transformation of the membrane during exosome biogenesis and the cholesterol levels (Chevallier 
et al., 2008; Matsuo et al., 2004). Lipidomic analysis showed normal levels of ceramide but 
abnormal sphingomyelin and LBPA accumulation in Tfam-deficient cells. These results indicated 
that accumulation of sphingomyelin precursors during ceramide synthesis is critical during ILV 
biogenesis and MVB maturation, regardless of the levels of LBPA or ceramides. Therefore, our 
results are consistent with the role of the neutral sphingomyelinase in exosome biogenesis, since 
inhibition of their activity, which reduces ceramide levels but promotes sphingomyelin 
accumulation, decreases ILV formation and exosome secretion (Trajkovic et al., 2008). 
Overall, we have identified a novel mechanism by which mitochondria exert a key 
regulatory role coupling lipid metabolism and endolysosomal system to preserve acquisition of T 
cell differentiation and effector functions. 
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6. Conclusions  
 
The findings presented herein support the following conclusions; 
 
1. The mitochondrial fission protein DRP1 regulates mitochondria localization towards 
nascent IS in coordination with the cytoskeleton transport machinery. 
 
2. Synaptic mitochondria control energy supply, IS architecture and TCR signaling, thus 
regulating the strength of T cell activation but also the termination of IS signaling. 
 
3. Mitochondrial OXPHOS regulates T cell activation, proliferation and differentiation.  
 
4. Mitochondrial dysfunction deviates T cell differentiation toward pro-inflammatory 
Th1 cell subsets in vitro and exacerbates inflammatory responses in in vivo models of 
inflammation. 
 
5. Mitochondrial respiration regulates endolysosomal function. Lysosome dysfunction in 
respiration-deficient cells link mitochondrial deficiencies with Lysosomal Storage 
Diseases (LSDs). 
 
6. Mitochondrial respiration regulates the endolysosomal compartment during 
inflammatory responses. Raising NAD+ levels improves lysosomal function and 
ameliorates inflammatory defects in respiration-deficient cells.  
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